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A.1 Adjusting the proportion of non-differentially
expressed genes
In order to make realistic power and sample size calculation the distribution
of effect sizes needs to be known. Ferreira and Zwinderman [2006], Jørstad
et al. [2008], Ruppert et al. [2007] have proposed method to estimate the dis-
tribution of effect size from pilot data, respectively using a deconvolution es-
timator, expectation-maximization algorithm or a spline-model. We use the
deconvolution estimator Ferreira and Zwinderman [2006]. The proportion of
non-differentially expressed genes, π0, is the first quantity to be estimated. The
empirical density of test statistics, m, is estimated from the set of test statistics
from the pilot data.
The deconvolution involves solving for λ following the equation
m (t)− π0φ (t)
1− π0 =
∫ +∞
−∞
φ
(
t− θ
√
N
)
λ (θ) dθ, (A.1)
where λ is the density of effect sizes, φ represents the density of the test statistics
and θ represents the effect size. The left hand-side of Equation A.1 expresses
the difference of the observed density of test statistics m with that of the
assumed density of test statistics under the null hypothesis (standard Normal,
φ), weighted by the proportion of non-differentially expressed genes. This is
linear combination of densities puts certain constraints to the value of π0. The
constrain can be formulated as:
min
i
(m (ti)− π0φ (ti)) ≥ 0⇒ π0 ≤ min
i
(
m (ti)
φ (ti)
)
. (A.2)
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This constraint is used to adjust the value of π0 in order to guarantee that the
estimated density of effect size is continuous and non-negative.
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Figure A.1: Adjustments of density of effect sizes: The three curves
solid(blue)-, short-dashed(pink)-, dotted(green)-lines represent respectively the
adjusted density, a density truncated near zero and the unadjust non-valid
density. With on the x-axis the standardized effect size and on the y-axis the
estimated density.
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Table A.1: Estimates of proportion of non-differentially expressed genes (π0)
using three different methods (Langaas, Storey and Ferreira), as well as esti-
mates of the power computed with the adjusted π0 that yield continuous and
non-negative densities.
power π0
a
Lang. Stor. Ferr. Lang. Stor. Ferr.
Affymetrix 0.31 0.31 0.30 0.76 0.61 0.75 0.61 0.59 0.56
Illumina 0.19 0.19 0.19 0.83 0.58 0.83 0.58 0.67 0.58
Agilent 0.44 0.44 0.54 0.48 0.37 0.46 0.37 0.22 0.22
HomeSpotted 0.19 0.19 0.20 0.64 0.40 0.62 0.40 0.41 0.37
Solexa 0.45 0.45 0.45 0.74 0.46 0.73 0.46 0.53 0.46
athe second column of each method represents the adjusted pi0.
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Figure A.2: Example 2: Power curves for three technologies and three intensity
ranges: The three panels show power curves for high-, medium-, low-intensity
range, with on the x-axis the sample size and on the y-axis the estimated
power using a 10% FDR. Each panel shows the power curves as function of
the sample size for three technologies Affymetrix (solid, blue), Agilent (short-
dashed, pink) and Solexa/Illumina dotted green). These plots were obtained
without the exclusion of a small region around zero, and show a slightly smaller
power for Solexa/Illumina compared to when this small region is not excluded
(figures 3.5 and 3.6). However, Solexa/Illumina still has superieur power to
find differential expression in the low-intensity range.
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B.1 Effect size in two-sample t-test, F -test and
likelihood ratio statistics
Here we will obtain expressions for the effect size θ and sample size N when
testing hypotheses in a linear or generalized linear model setting.
First we review the special case of inference on a linear model involving a
dichotomous response variable: the two-sample t-test. Consider the simple sit-
uation of independent samples from two normally distributed random variables
Xi ∼ N(µX , σ2) and Yj ∼ N(µY , σ2), with i = 1, . . . , NX and j = 1, . . . , NY .
The usual statistic for testing H0 : µX − µY = 0 against Ha : µX − µY 6= 0 is
the two-sample t-test statistic
T =
X¯NX − Y¯NY
Sp
√
1/NX + 1/NY
, (B.1)
where X¯NX and Y¯NY represent the sample means of the groups and Sp the
pooled sample variance. The effect size is defined as the standardized difference
between the means θ = σ−1(µX−µY ). If the means of the groups are identical,
the effect size is zero (θ = 0) and the test statistic has a central Student’s
t-distribution. A non-central t-distribution with non-centrality parameter δ
arises when the effect size is different from zero (θ 6= 0).
The non-centrality parameter can be written as δ = θ
√
N where N =
NX +NY is the total sample size and θ the effect size which has absorbed the
group proportions pX and pY . The experimental design of the pilot and follow-
up experiment are consider to be the same only the sample size will differ and
thus the group proportions are fixed.
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Now we derive the result that the effect size δ is proportional to N ; the
total number of samples in a two-group design. For a two-sample t-test the
non-centrality parameter of the Student’s t distribution can be expressed as
δ =
µX − µY
σ
√
1/NX + 1/NY
. (B.2)
Some little algebra shows that the square-root expression can be written as√
NpXpY where pX and pY represent the proportion of samples in group X
and Y compared to the total number of samples.
(
1
NX
+
1
NY
)−1
=
NXNY
NX +NY
(B.3)
= (NX +NY )
NX
NX +NY
NY
NX +NY
(B.4)
= NpXpY (B.5)
From this it follows that
√
NpXpY θ = δ =
√
Nθ˜, where θ˜ =
√
pXpY (µX−µY )/σ.
A general hypothesis for the linear model, when multiple groups are in-
volved, will lead to an F -test with (non-)central F -distribution under the
null(alternative) hypothesis. Now we will explicitly show the relation between
the non-centrality parameter, effect size and sample size.
Consider the linear model y = Xβ+ǫ where yN×1,XN×p, βp×1 and assume
i.i.d. normal errors. We will focus on hypotheses that can be expressed as a
linear combination of the model parameters,
H0 : L
Tβ = ψ0, Ha : L
Tβ 6= ψ0 (B.6)
where Lp×q represents the contrast matrix and ψ0 is a q × 1 vector of constants
appropriate to the research question. Test statistics can be derived by compar-
ing the residuals sums of squares of the null model with that of the alternative
model, or by the likelihood ratio. Both lead to the F -test statistic
F =
1
qσˆ2
(LT βˆ)T [LT (XTX)−1L]−1(LT βˆ), (B.7)
where σˆ2 represents an estimator of the error variance σ2. The test statistic F
is distributed under H0 as a central F -distribution Fq,N−p and, under Ha, as
a non-central F -distribution Fq,N−p(δ) with non-centrality parameter
δ =
1
σ2
(LTβ)T [LT (XTX)−1L]−1(LTβ). (B.8)
Again assuming a fixed design for the pilot and follow-up experiment, again δ
can be expressed as the product of the total sample size and a part representing
140
B.1. EFFECT SIZE
the effect size δ = θN .
Now we provide a proof for the statement that the effect size δ is propor-
tional to N in a multi-group, K-sample design. Write X = (1N,X1, . . . ,XK),
where Xj codes for the jth group: Xj = (0
n˜1,j−1 ,1nj ,0n˜j+1,K ), with nj : sam-
ple size of group j, n˜u,v =
∑v
ℓ=u nℓ and 1
q (0q) denotes a vector of q 1’s
(0’s). Then, XTX results from all inner product of the columns of X, which
are: (1N )TXj = X
T
j 1
N = nj = pjN, (1
N )T1N = N,XTj Xj = nj = pjN and
XTj Xk = X
T
k Xj = 0, for j 6= k. Therefore, N can be factored out for each of
the elements of XTX and hence also for δ:
δ =
N
σ2
(LTβ)T [LTW−1L]−1(LTβ), (B.9)
with W = (wij)
K+1
i=1,j=1, w11 = 1, w1j = wi1 = wjj = pj , for i, j > 1 and
wij = 0, otherwise.
For inference in the generalized linear model setting, only approximated
distributions are known for the alternative hypothesis [Self and Mauritsen,
1988, Mauritsen et al., 1992, Shieh, 2000].
Consider independent random variables Yi, i = 1, . . . , N , that follow a prob-
ability distribution belonging to the exponential family of distributions. The
mean response E[Y ] = µ is linked through a link function g to the linear predic-
tors as µ = g−1(Xψ) [McCullagh and Nelder, 1989]. Inference on ψ is usually
based on the likelihood-ratio statistic, where the null hypothesis H0 : ψ = ψ0 is
tested against the alternative Ha : ψ 6= ψ0, with ψ a p×1 vector. Furthermore,
we assume the scale parameter of the distribution of Y to be known. Then un-
der H0 the likelihood-ratio statistic has approximately a χ
2-distribution with
p degrees of freedom. Shieh [2000] showed that under Ha the likelihood-ratio
statistic follows approximately a non-central χ2 with p degrees of freedom and
non-centrality parameter
δ = NEX[2a
−1(τ){b′(τ)[τ − τ∗]− [b(τ)− b(τ∗)]}], (B.10)
where τ represents the canonical parameter and τ∗ its maximum likelihood
estimate under certain limiting conditions [Self and Mauritsen, 1988, Shieh,
2000], and the expectation is taken with respect to the covariate distribution.
For simplicity, we have ignored the possibility of a nuisance parameter (this
is a simplification of the result by Shieh [2000]). We do not need to specify
the covariate distribution explicitly; the only thing that matters to us is that
this expression is again sample size times a factor that we will call effect size;
δ = θN .
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B.2 General formula for mixture density and
distribution functions
Here we present general formula for mixture density and distribution functions.
In these formula we will focus on the non-centrality parameter and ignore oth-
ers like the degrees of freedom if they are present.
Symmetric null distribution:
The cumulative distribution function for a mixture with symmetric null distri-
bution for the test statistic is given by
F (x) = π0F0(x) + (1− π0)
∫ +∞
−∞
F1(x, θN)fΘ(θ)dθ, x ∈ [−∞,+∞]. (B.11)
The product θN represents the non-centrality parameter where N is a param-
eter reflecting the sample size. The probability density function for a mixture
with symmetric null distribution for the test statistic is given by
f(x) = π0f0(x) + (1− π0)
∫ +∞
−∞
f1(x, θN)fΘ(θ)dθ. (B.12)
Because interchanging integration with differentiation is allowed (Dominated
Convergence Theorem) equation (B.12) is easily derived from equation (B.11).
Fs and fs are i.e. the Normal and Student’s t distribution and density func-
tions. The subscript s = 0 indicates the density or distribution function under
the null and s = 1 under the alternative.
As the null distribution is known equivalently cumulative distribution or prob-
ability density function for a mixture for the p-values can be constructed. For
symmetric null distribution two-sided p-values are calculated and thus the cu-
mulative distribution function for a mixture based on p-values becomes
G(u) = π0u+ (1− π0)
∫ +∞
−∞
{1− F1(F−10 (1− u/2), θN)+
F1(−F−10 (1− u/2), θN)}fΘ(θ)dθ, u ∈ [0, 1]. (B.13)
The probability density function of the symmetric mixture of p-values is given
by
g(u) = π0+(1−π0)
∫ +∞
−∞
f1(F
−1
0 (1− u/2), θN) + f1(−F−10 (1− u/2), θN)
2f0(F
−1
0 (1− u/2))
fΘ(θ)dθ.
(B.14)
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asymmetric null distribution:
The cumulative distribution function for a mixture with asymmetric null dis-
tribution is given by
F (x) = π0F0(x) + (1− π0)
∫ +∞
0
F1(x, θN)fΘ(θ)dθ, x ∈ [0,+∞]. (B.15)
The probability density function of the asymmetric mixture of test statistics is
given by
f(x) = π0f0(x) + (1− π0)
∫ +∞
0
f1(x, θN)fΘ(θ)dθ. (B.16)
For asymmetric null distribution one-sided p-values are calculated and thus the
cumulative distribution function becomes
G(u) = π0u+ (1− π0)
∫ +∞
0
{1− F1(F−10 (1− u), θN)}fΘ(θ)dθ, u ∈ [0, 1].
(B.17)
The probability density function of the asymmetric mixture of p-values is given
by
g(u) = π0 + (1− π0)
∫ +∞
0
f1(F
−1
0 (1− u), θN)
f0(F
−1
0 (1− u))
fΘ(θ)dθ. (B.18)
B.3 Discretization of the inverse problem
By differentiating both sides of equation (B.11) and observing that it is allowed
to interchange differentiation with integration (by the Dominated Convergence
Theorem, since both Fa and fΘ are bounded and the derivative of Fa with
respect to t exists) the following equation can be derived
f(t) = π0f0(t) + (1− π0)
∫ b
a
fa(t; θN)fΘ(θ)dθ, (B.19)
where the integration limits represents the support of Θ. From the observed
set of test statistics an estimate fm of f is constructed e.g., by binning on ti
for i = 1, . . . , I. Furthermore, it is always possible to approximate an integral
by a summation. For example, using the midpoint rule with ∆θ = (b−a)/(J−1)
and θj = a+ (j − 1)∆θ for j = 1, . . . , J , equation (B.19) becomes a system of
equations
fm(ti) = π0f0(ti) + (1− π0)
J∑
j=1
fa(ti, θjN)fΘ(θj)∆θ, (B.20)
for i = 1, . . . , I. Using matrix notation this system of equations can concisely
be represented by
Ax = b, (B.21)
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where AI×(J+1) is a matrix with first column f0(ti) and remaining J columns
fa(ti, θjN)∆θ for i = 1, . . . I and bI×1 is a column vector with elements fm(ti)
for i = 1, . . . I. The column vector of unknown coefficients, x(J+1)×1, represents
(π0, (1− π0)fΘ(θ1), · · · , (1− π0)fΘ(θJ ))T . (B.22)
Equation (B.21) looks like an ordinary regression problem, but unfortunately
the matrix A is ill-conditioned and the inverse does not exists. Especially
when the integral is approximated on a fine grid (∆θ small or J large), two
consecutive columns of A become nearly identical, Aij ≈ Aij+1 (fa(ti, θjN) ≈
fa(ti, θjN + ∆θN)), and A is not of full column rank. The same problem
occurs in a multiple regression model where two or more covariates are highly
correlated.
B.4 Similarity between AIC and GCV on logarithmic
scale
The GCV on the log-scale is closely related to Akaike’s information criterion.
The AIC is given by
AIC(λ) = log ||b−Axλ||22 + 2
tr(Sλ)
n
, (B.23)
where Sλ = A(A
TA+ λ2I)−1ATb. The GCV is given by
GCV(λ) =
||b−Axλ||22(
1− tr(Sλ)n
)2 . (B.24)
Using the following identity log(x) ≤ x − 1 for 0 < x < 1, which is allowed
since 0 < tr(Sλ) ≤ n.
logGCV(λ) = log ||b−Axλ||22 − 2 log
(
1− tr(Sλ)
n
)
≤ log ||b−Axλ||22 + 2
tr(Sλ)
n
≤ log ||b−Axλ||22 + 2
tr(Sλ)
n
.
This connection is also described in Takezawa [2006] (page 129), but derived
differently:
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eAIC(λ) = ||b−Axλ||22 e
2
n
tr(Sλ)
=
||b−Axλ||22(
e−
1
n
tr(Sλ)
)2 (B.25)
=
||b−Axλ||22(
1− tr(Sλ)n
)2 ,
where the identity 1− x ≤ e−x is used.
A similar equivalence exists between the GCV and Mallow’s Cp (see Ruppert
et al. [2003], Chapter 5, page 119-120). Also Hastie et al. [2001] noticed the
similarity between GCV and AIC, however, they used the approximation 1/(1−
x)2 ≈ 1 + 2x.
B.5 The solution to a least-squares problem lies in the
Krylov space
In order to show that the solution to a least-squares problem lies in the Krylov
space we use the Cayley-Hamilton theorem (see e.g. page 575-576 of Harville
[2008]). The Cayley-Hamilton theorem states that χA(A) = 0 where χA(t) =
det(tλ −A) is the characteristic function of A. For example, given the eigen-
values λ1, . . . , λn of an n × n matrix A the characteristic function is given by
χA(t) =
∏n
i=1(t − λi) or
∑n
i=0 αit
i represented as a sum of powers of t. As a
result of the Cayley-Hamilton theorem it follows that we can write the inverse
of A as a finite sum of powers of A:
α0In + α1A+, · · · ,+αnAn = 0 (B.26)
α0In = −α1A−, · · · ,−αnAn (B.27)
In = −α1
α0
A−, · · · ,−αn
α0
An (B.28)
A−1 = −α1
α0
In−, · · · ,−αn
α0
An−1. (B.29)
Now we can rewrite x = A−1b or x = (ATA)−1AT b for the general case when
A is not a square-matrix, using the previous expression for A−1. The result-
ing solution is a linear combination of {ATb, (ATA)ATb, . . . , (ATA)k−1ATb}
and thus lies in the Krylov-space.
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B.6 Some implementation details:
Automatic selection of the regularization parameter
The L-curve and S-curve are curves given parametrically as
L(λ) = (log ||b−Axλ||2 , log ||xλ||2) and G(λ) see equation (B.24). The cor-
ner of these curves can be located by evaluating the curvature, especially the
maximum or minimum locates the corner.
For a plane curve given parametrically in Cartesian coordinates as γ(t) =
(x(t), y(t)), the curvature is
κ =
x′y′′ − x′′y′
(x′2 + y′2)3/2
, (B.30)
where ′ indicates the derivative with respect to t. Hansen [2010] derived an
analytic expression for the curvature of the L-curve we derived in a similar way
expression for the S-curve. Once these expression are obtained automatically
the regularization parameter can be selected.
Solving discrete inverse problem: Non-negative Conjugate
Gradient
We modified the cgmin C-implementation of the Conjugate Gradient algo-
rithm from the R [R Development Core Team] source code in such a way
that we could add our stopping rule. An implementation is available from
the R/BioConductor-package SSPA.
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Figure B.1: Example 1: Relative error, formula (2.9) of the Main text, as
function of the number of iterations for the Conjugate Gradient method (upper
panel) and the Tikhonov regularization parameter λ (lower panel). Note that
the x-axis of the lower panel is reversed. Both optimal number of iterations
and regularization parameter are indicated by ×.
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Figure B.2: Boxplots of 250 independent π0 estimates from simulated data
based upon a ’true’ standard normal density of effect sizes, using 7 different
methods: convest [Langaas et al., 2005], qvalue[Storey, 2003], our proposed
nncg method and the four methods proposed by Long et al. [2012]. Each of the
250 simulated data sets involves two groups, with 5 independent samples each.
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Figure B.3: Boxplot of Hellinger distances between 250 estimated density of
effect sizes, from simulated data based upon a ’true’ standard normal density
of effect sizes, using our proposed nncg method and the four methods proposed
by Long et al. [2012]. Each of the 250 simulated data sets involves two groups,
with 5 independent samples each.
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Figure B.4: Boxplots of 250 π0 estimates, each from a simulation study with
a bimodal density of effect sizes, using 7 different methods: convest [Langaas
et al., 2005], qvalue[Storey, 2003], our proposed nncg method and the four
methods proposed by Long et al. [2012]. Each of the 250 simulated data sets
involves two groups, with 5 independent samples each.
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Figure B.5: Boxplot of Hellinger distances between 250 estimated density of
effect sizes with the ’true’ bitriangular density of effect sizes, using our proposed
nncg method and the four methods proposed by Long et al. [2012]. Each of the
250 simulated data sets involves two groups, with 5 independent samples each.
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Figure B.6: Example 3: Estimated π0, average power, normalization constant
for a) full sized data indicated with horizontal dashed lines and b) for 25 subsets
of half the size of the data indicated with box-plots, using the three methods
A, B and C.
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Figure B.7: Example 5: Upper panel: Estimated density of effect sizes using
estimation method A (solid), B (dashed) and C (dotted). Lower panel: estimate
power curves for sample sizes up to 5× larger than the pilot data where a small
region around zero is excluded from the density of effect sizes.
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C.1 Study design
Here we assume a study setup commonly found in practice, involving gene
expression profiles of two groups of independent samples,with the null hypoth-
esis representing no differential expression between the two groups for any
given gene, and a corresponding two-sided alternative. With notation, as-
sume that the two independent groups of samples have sample sizes nX , nY
(nZ = nX + nY ) and that each sample has a corresponding mRNA profile
including m features (probes or genes, say). So the data consists of two matri-
ces, X = [X1,X2, . . . ,XnX ] and Y = [Y1, Y2, . . . , YnY ]. Let Z = [X,Y ] be the
matrix including all samples from both groups. Gene-wise sample means are
represented by m× 1 vectors X¯nX , Y¯nY for each group separately, and by Z¯nZ
for all samples. Similarly, gene-wise sample variances are represented by m× 1
vectors S2X , S
2
Y for each group separately and by S
2
Z for all samples.
A test statistic M = M(Z) is computed to test the null hypothesis H0 :
µX = µY against the alternative Ha : µX 6= µY . If V is a binary m × 1
vector with Vi = 1 whenever H0 holds for feature i, and Vi = 0 otherwise, then
π0 = (1
tV )/m represents the proportion of features that follow H0. Then the
distribution F of M can be written as
M ∼ π0F0 + (1− π0)Fa, (C.1)
where F0,Fa are evaluated under H0,Ha, respectively. We shall represent by
f and F the probability density function (pdf) and the cumulative density
function (cdf) corresponding to F , respectively where, as above, indices when
used indicate the holding hypothesis. Here we assume that F0 is a symmetric
distribution around a value k for convenience, i.e., its density function satisfies
f(k − u) = f(k + u) for a given k and all u, both real numbers.
Let also P = (P1, P2, . . . , Pm)
t be the vector of p-values computed for the
observed data. Then we can write that the distribution G of P is a mixture
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between its distribution under H0 and under Ha, respectively G0,Ga, i.e.,
P ∼ π0G0 + (1− π0)Ga, (C.2)
and it is a well-known fact that G0 = U [0, 1]. Similarly to the test statistic,
G, g shall represent the cdf and pdf of G respectively.
C.2 Selecting features - the filter
Features may be selected from the data to be kept in the analysis. Such selec-
tion is defined by a filter statistic W =W (Z), a measure to be computed from
the data, and a threshold w that indicates if the feature is kept or not. Here
we are mostly concerned with evaluating the effects of different types of filter
statistics, so we shall keep filter thresholds w fixed and, whenever possible,
comparable across various filter statistics. In formulae below subscripts will be
omitted when they are obvious, for the sake of clarity. For given choices ofW,w,
applying the filter to the dataset is equivalent to evaluating the indicator func-
tion I{W (Zi) ≥ w} ≡ Ri for each feature i, yielding R = (R1, R2, . . . , Rm)t, a
m × 1 vector indicating which features are left in the data. Thus the fraction
of the total number of features taken further for analysis is γ = (1tR)/m.
In this context, the filtered dataset and p-values can be represented by
ZW = diag{R}Z and PW = diag{R}P , respectively, where
diag{R} ≡ diag{R1, R2, . . . , Rm}, a diagonal matrix of the elements of R. From
equation (C.1), the distribution FW of MW , the test statistic after filtering, is
given by the mixture
MW ∼ πW0 FW0 + (1− πW0 )FWa , (C.3)
where πW0 = (1
tdiag{R}V )/m represents the proportion of null features after
filtering. Similarly for the filtered p-values, we have from (2)
PW ∼ πW0 GW0 +
(
1− πW0
)GW0 . (C.4)
C.3 Distribution of p-values
It is expected that, after filtering, the threshold for significance will increase.
However, it does not necessarily follow that the filtered data yields more power
to detect differential expression, as some filter statistics may leave out features
that do not follow H0. In addition, the increased significance threshold may
no longer correctly estimate the error, if the filtering method does not select
null p-values from the entire range with equal probability as we have shown
above. In order to evaluate these aspects, we need to consider the effect each
filter statistic has on the p-values distribution, under both H0 and Ha.
First let us consider how p-values are generated. Assume for simplicity that
the analysis used involves a symmetric distribution around 0 F0 for the test
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statisticM and a two-sidedH0 rejection region. This is the case in most studies
as the one we consider here. Then the p-values are given by
P = 2 [1− F0 (|M |)] . (C.5)
In particular, for null features we have P0 = 2 [1− F0 (|M0|)], where M0 rep-
resents the test statistic M under H0, so that it follows F0. It is well known
that this implies that P0 ∼ U [0, 1]. One possible proof follows.
Let M ∼ F with corresponding cdf F , and suppose we are testing H0 :
E(M) = 0 against Ha : E(M) 6= 0. Then a p-value after observing M = x0
can be calculated as
P = P{M > |x0|} = P{M > |x0|}+ P{M ≤ −|x0|}
= 1− P{M ≤ |x0|}+ P{M ≤ −|x0|}
= 1− F (|x0|) + F (−|x0|)
= 1− F (|x0|) + 1− F (|x0|),
where we have used the fact that F0 is symmetric around zero, meaning that
F (−u) = 1−F (u).Thus we have, for any possible value of M , that the p-value
is
P = 2[1− F (|M |)].
The distribution of P can now be evaluated as follows:
GP (p) = P{2[1− F (|M |)] ≤ p}
= P{1− F (|M |) ≤ p/2}
= P{1− p/2 ≤ F (|M |)}
= P{F−1(1− p/2) ≤ |M |}
= 1− P{|M | ≤ F−1(1− p/2)}
= 1− {F [F−1(1− p/2)]− F [−F−1(1− p/2)]}
= 1− {F [F−1(1− p/2)]− 1 + F [F−1(1− p/2)]}
= 1− {2F [F−1(1− p/2)]− 1}
= 2− 2F [F−1(1− p/2)]
= 2− 2(1− p/2)
= p.
So, we can conclude that p-values have a uniform distribution over [0, 1], so
long as the distribution of the test statistic M is F, the same used to compute
the p-values. Similar proofs can be obtained for the simpler cases of one-sided
alternatives.
After filtering, a similar relation holds. Indeed, we would then have PW0 =
2
[
1− F0
(|MW0 |)], where MW0 has cdf FW0 . Then the cdf for PW0 is
GW0 (p) = 2
{
1− FW0
[
F−10 (1− p/2)
]}
(C.6)
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and, in case the filter selects null p-values from the entire range with equal
probability, we have FW0 = F0 and P
W
0 ∼ U [0, 1], as before filtering. However,
if FW0 6= F0, the cdf of the p-values does not correspond to the uniform. How
far it is from the uniform depends on how the filter statistic W used affects F0.
In order to evaluate this, we must consider a test statistic and the commonly
used filter statistics given in the Methods section of Chapter 5.
C.4 Filtering and p-values distribution
Once an expression for the pdf of the test statistics after filtering is obtained, we
can obtain the pdf and cdf of the p-values using the relation P = 2[1−F0(|M |)]
(see Section C.3). For expressions corresponding to some of the filter statistics,
see Section C.7.
GWb (p) = 1− FWb
(
F−10 (1− p/2)
)
+ FWb
(−F−10 (1− p/2)) (C.7)
and
gWb (p) =
1
2
(
fWb
(
F−10 (1− p/2)
)
+ fWb
(−F−10 (1− p/2)))
f0
(
F−10 (1− p/2)
) . (C.8)
By plugging-in the derived pdf and cdf of the filter statistics, we can display
the effect of each filter on the null and alternative distributions of p-values (see
Figure 5.1).
C.5 FDR methods and p-values distributions
We have pointed out that filtering may alter the null distribution of p-values
under certain conditions (see Section 5.2). So in order to evaluate the effect
of filtering on the FDR, it is useful to express it in terms of the p-values cdf,
which is possible in some cases [Finner et al., 2007]. Indeed, the BH, aBH and
BY methods can all be re-written as follows: to control the FDR at φ, reject
all hypotheses i in the set
{i : Pi ≤ u∗(φ)} , (C.9)
where
u∗(φ) = max
u
{g(u, φ) ≤ G(u)} , (C.10)
G represents the general p-values cdf, and
g(u, φ) = u/φ, for BH, and,
g(u, φ) = (π0)u/φ, for aBH.
Note that, if all features are null, the set given by equation (C.9) is likely to be
empty for all g(u, φ) considered.
An intuition behind this representation follows. If all features are null and
independent, the p-values cdf G will correspond to that of a uniform in [0, 1],
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represented by a straight line from (0, 0) to (1, 1). If these assumptions are
violated, typically G will become concave with G(u) >= u for u ∈ [0, 1]. The
Benjamini-Hochberg FDR can be seen in this context as multiplying the angle
of the null cdf by 1/φ, so that G(u) ≥ u/φ is expected to involve by chance φ%
null features. Under the adaptive Benjamini-Hochberg, the angle is corrected
by the proportion of null features, becoming less strict.
Benjamini-Yekutieli’s method can be expressed in a similar form, with u∗i (φ)
instead of u∗(φ) in equation (C.9), where
u∗i (φ) = max
u
{g(ui, φ) ≤ G(u)} = max
u

uφ
i∑
j=1
1
j
≤ G(u)

 ,
which means that, in this case, the angle correction depends on the cardinality
of the set of selected p-values.
Here g(ui, φ) represents the secant establishing which part of the cdf Gm
can be generated by chance, and which part cannot. The functional form of
the function gives some insight into how each FDR method works: for BH the
threshold depends on φ only, for aBH it also involves the proportion of null
features and, finally, for BY it is a function of how many features are selected.
From section C.3 we have that the cdf for p-values is given by
G(p) = 2
{
1− F0
[
F−1 (1− p/2)]} , 0 ≤ p ≤ 1, (C.11)
where F, F0 represent the general and the null cdf’s of the test statistic. Re-
placing equation (C.11) into equation (C.10) yields
u∗(φ) = max
u
{
F−10 [1− g(u, φ)/2] ≤ F−1(1− u/2)
}
,
which can be evaluated for given F, F0.
If we define, for each hypothesis i(i = 1, . . . ,m),
Ii =
{
1 if Pi ≤ u∗(φ)
0 if Pi > u
∗(φ)
then the expected number of rejected hypotheses, which is the expected cardi-
nality of the set given by equation (C.9), can be evaluated as
E
(
m∑
i=1
Ii
)
=
m∑
i=1
E (Ii) =
m∑
i=1
P {Pi ≤ u∗(φ)} . (C.12)
The above development can also be used in the general case where alterna-
tive features are observed.
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C.6 FDR and Power as function of fraction filtered out
The total number of hypotheses is m of which m0 are calculated under H0 and
m1 under H1. If we assume that the total number of hypotheses will decrease
linearly with the fraction, 1− γ, filtered out we get for m(1− γ):
m(1− γ) = mγ 0 ≤ γ ≤ 1 (C.13)
Now we assume an ideal filter removing first only features that followH0. When
γ = 1− π0, all null features are removed and
m0(x) =
{
m0 −mx 0 ≤ x ≤ π0
0 π0 < x ≤ 1
m1(x) =
{
m1 0 ≤ x ≤ π0
m(1− x) π0 < x ≤ 1
The proportion of features under H0 as a function of the fraction removed
is given by:
π0(x) =
{
π0−x
1−x 0 ≤ x ≤ π0
0 π0 < x ≤ 1
The original FDR correction method of Benjamini-Hochberg can be re-
written as an inequality involving the mixture distribution of p-values, Gm(u):
u∗ = max {u/φ ≤ Gm(u), 0 ≤ u ≤ 1} , (C.14)
where u represents possible values of the random variables {Pi}
The mixture distribution consists of a uniform distribution and an alterna-
tive distribution with mixture coefficient π.
Gm(u) = π0u+ (1− π0)Ga(u)
By plugging in a suitable functional form for the alternative distribution it is
possible to solve equation (C.14) for u∗. Langaas and others suggest a beta-
distribution for the alternative Beta(1, b). The choice of a = 1 makes equation
(C.14) difficult to solve. But when b = 1 and 0 < a < 1 the equation is easily
solved and the alternative distribution still seems realistic. First plugging in
the proportion of hypotheses under H0 as function of the fraction removed,
π0(x):
u∗ = max
{
u/φ ≤ π0 − x
1− x u+
1− π0
1− x u
a
}
(C.15)
We immediately see the u∗ = 0 is the trivial solution, but there also exists a
solution 0 < u∗ < 1, which is given by
u∗ =
(
1− x
φ(1− π0) −
π0 − x
1− π0
)1/(a−1)
(C.16)
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For equation (C.16) to hold we must assume that the filter applied is an ideal
filter removing null hypotheses only first. And when we are left with only
alternative hypotheses the FDR remains constant.
C.7 Density of test statistics after filtering
If we have a random variable Z = g(X,Y ) where the X and Y are two other
independent random variables that is case e.g. for the Student’s t test-statistics
and Snedecor’s F statistics. Then the follow formula can be used to derived
the probability density of Z:
fZ(z) =
∫
∂g−1(z; y)
∂z
fX(g
−1(z; y))fY (y)dy (C.17)
For example: Student t, T = Z√
V/n
= g(Z, V )⇔ g−1(T ;V ) = T√V/n = Z and
using ∂g
−1(T ;V )
∂t =
√
v/n we get:
fT (t) =
∫ ∞
0
√
v/n
e−
1/2(t
√
v/n)2
√
2π
v
n
2 −1e−n/2
Γ
(
n
2
)
2
n
2
dv =
Γ
(
n+1
2
)
Γ
(
n
2
)√
nπ
(
1 + t
2
/n
)1/2(n+1)
,
(C.18)
where the integration limits are over the support of V .
If either X, Y or any transformations of these are the filter statistics, we can
derive in a similar fashion as equation (C.18) the distribution of the test statis-
tics after filtering. For example if the filter statistics is X and, say, we filter on
the absolute value of |x| the integration will be over the support of Y excluding
a region according to I (|x| ≥ ω) = I (|g−1(z; y)| ≥ ω) = I (|y| ≥ h(z, ω)):
fZ(z) =
∫
I (|y| ≥ h(z, ω)) ∂g
−1(z; y)
∂z
fX(g
−1(z; y))fY (y)dy (C.19)
Again in case of the Student’s t test statistics, filtering on the absolute value
of the fold-change we get:
fT (t) =
∫ ∞
0
I
(
|t
√
v/n| ≥ ω
)√
v/n
e−
1/2(t
√
v/n)2
√
2π
v
n
2 −1e−n/2
Γ
(
n
2
)
2
n
2
dv (C.20)
fT (t) =
∫ ∞
nω2
t2
√
v/n
e−
1/2(t
√
v/n)2
√
2π
v
n
2 −1e−n/2
Γ
(
n
2
)
2
n
2
dv (C.21)
The last integral can be re-written as the product of a central Student’s t
density and a modified gamma-distribution function fT (t;n)FΓ(1+n/t2; 2/ω2, n+1/2).
The density function for other filters that have a relation to the test statistics
are derived similarly. Under the alternative the derivations becomes more dif-
ficult and numerical integration is used for evaluation of the density function
after filtering.
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C.8 Simulation study setup
To investigate the properties of the filtering on high-dimensional datasets, a
simulation study is carried out. We use a setup that mimics a microarray
experiment where thousands of genes are measured simultaneously, based upon
a setup first suggested by Langaas et al. [2005].
A total of m = 5000 features were generated independently for each of
n = 10 samples per group. Let Rij and Sij , i = 1, . . . ,m, j = 1, . . . , n be
random variables Sij ∼ N (−µi/2, 1) and Rij ∼ N (µi/2, 1) with the first µi = 0
for i = 1, . . . ,m0 and the remaining µi for i = m0 + 1, . . . ,m were drawn from
a symmetric bitriangular distribution as described by Langaas et al. [2005].
A total of N = 1000 datasets were simulated with the proportion of non-
differentially expressed features fixed at π0 = 0.8. Additional noise is added to
the model using X ∼ log(eR + eǫ) and Y ∼ log(eS + eǫ) with ǫ ∼ N(0, 0.01),
so that the noise is positive and additive.
Two-sample Student-t test statistics were calculated and converted to two-
sided p-values accordingly. FDR-based multiple testing correction methods
used were the ones suggested by: Benjamini and Hochberg [1995], Benjamini
and Yekutieli [2001], Benjamini et al. [2006] and Storey [2002]. For each sim-
ulated dataset, both the achieved FDR (fraction of false positives amongst
features below FDR threshold) and the observed power (fraction of p-values
below FDR threshold belonging to non-null features, out of all 4000 non-null
features) were calculated.
Dedicated R [R Development Core Team] functions were used in the compu-
tations. Specifically, forthe multiple testing correction methods the multtest
and qvalue package were used.
In order to compare the different filter methods the same fraction was re-
moved based on the empirical quantiles of the filter statistics. Note that FDR
estimation using the qvalue method relies on p-values taking values on the en-
tire [0, 1] interval. Thus, we only used the variance and signal filter statistics
with this method. Using the bootstrap method for estimation of the optimal λ
[Storey, 2002] does not the make the FDR estimable.
The behaviour of π0(γ) for the best filter possible can be described as fol-
lows. The number of features M(γ) will decrease linearly with the fraction
removed, so M(γ) = m(1− γ), while the number of alternative features M1(γ)
remains constant and equal tom1. Thus, the number of null featuresM0(γ) will
decrease according to m0 −mγ. This implies that π0 (γ) = (π0 − γ) / (1− γ),
which is a concave decreasing function for γ in [0, π0]. A bad filter would leave
out both null and non-null features with equal probability, so we refer to it as
a random filter. For such a filter, π0(γ) stays around π0 as γ decreases, finally
going to zero as all features are eliminated.
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Figure C.1: Relationship between filter statistics, with each dot representing
one feature and its colour indicating the hypothesis: blue = H0, red= Ha. The
scatterplot on the left panel is the same as the one on its right. The green area
underlying the plots marks the features that would be filtered out if 25% of
them were to be excluded, using each filter. The filter in the bottom-left hand
corner uses the test statistic itself, and is included to yield a contrast with the
variance filter.
Illustration of filter statistics
We shall show how each filter statistic affects power and FDR estimates using
one of the simulated datasets chosen at random. In figure C.1 we can see that
the filter statistics used have little association with each other, as evidenced by
the lack of pattern described by the dot clouds. This implies that they indeed
look at different aspects of gene expression. It is also clear that, when using any
of these filter statistics, there is always a fraction of the differentially expressed
features that is left out, for which the power is automatically set at zero.
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Relationship between achieved FDR and power
Here we examine further aspects of power and observed FDR variation, as a
result of increasing proportions of features being left out of the data. Firstly,
we see from figure C.2 that the power displays similar behaviour to that of the
FDR (figure 5.5), as expected. Indeed, FDR methods yielding larger observed
FDR do so because they involve larger thresholds for significance, which tend
to yield also a larger power. What we can also see is that this depends on the
filter statistic, as for the FDR: the ones that introduce the least bias on the
FDR also yield the lowest power.
Another important aspect to examine is the relationship between observed
power and FDR, for different filter statistics (figure C.3). Here we use only BH
for FDR correction for illustration, with results obtained using other methods
yielding similar conclusions. Filter statistics that are more closely related to the
hypothesis tested (left hand-side panels in the figure) yield essentially the same
relationship between achieved power and FDR, regardless of the filtered-out
proportion. This means that the cost-benefit relation of using filtering remains
the same. On the other hand, for the filter statistics that are unrelated to
the hypothesis tested (right hand-side panels) the cost-benefit-relationship gets
worse, with the power decreasing for increasing proportions of left-out features.
C.9 A test for filtering-induced FDR bias
The test
In section 5.2, we have shown that a necessary condition for the null distribution
of p-values after filtering to still follow a U [0, 1] is that the filter selects null
features at random from their entire range [0, 1]. This motivates a hypothesis
test to check in practice if this condition holds.
Let P0 ∼ U [0, 1] be the m × 1 vector of p-values generated if all features
in the data followed H0. Then generate a number N0 of observations P0i of
this vector by permuting row and column labels of the data. For each per-
mutation, apply the filter W to the data, leaving only γm of the entries in
each P0i. Subsequently, compare each shortened vector P0i to its null dis-
tribution U [0, 1] by means of a Kolmogorov-Smirnov test, generating p-values
(Q1, Q2, . . . , QN0) ≡ Q. If the filter selects null features randomly from their
entire range, then it follows that Q ∼ U [0, 1], which can again be assessed by a
Kolmogorov-Smirnov test.
In order to enable fair estimation of the null p-values distribution, we per-
mute column labels for each row, independently per row. Here the column
label permutation eliminates any association between gene expression levels
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Figure C.2: Actual power as function of the fraction filtered out for the different
filter statistics, fixing the FDR with each method at 0.05. Values shown are
the mean observed power over 1000 simulated datasets (the variability of the
power is small - not shown). Filters are: dashed dotted line = fold change,
dotted = signal, solid = variance, dashed = t-test statistic. This last filter is
included for comparison with the fold-change filter. In all cases the proportion
of differentially expressed genes is fixed at 0.20. Results of the q-value method
could only be obtained for the variance and signal filter, as for the fold change
and test-statistic ones the p-value range was reduced, violating an assumption
of the method.
and clinical variables, whilst applying the permutations independently per row
eliminates associations between probes.
Another important point is to find filter effects on the null p-value distri-
bution that yield under-estimation of the FDR. This is considered to be the
worst error, making results look more optimist than they really are. In order
to do so, we compare the empirical distribution of the filtered null p-values GˆW0
to the uniform U , against the alternative that the former is super-stochastic,
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Figure C.3: Relationship between actual power (y-axis) and achieved FDR(x-
axis) for various filtered-out fractions (0, black; then in gray shades increasing
by steps of 0.1) for the different filter statistics, fixing the FDR control with
the BH method at 0.05. In all cases the proportion of differentially expressed
genes is fixed at 0.20.
i.e. GˆW0 (u) ≥ G0(u) for all u ∈ [0, 1]. This can be done with the Kolmogorov-
Smirnov test, and the Benjamini-Hochberg FDR step-up method [Benjamini
and Hochberg, 1995] is equivalent to it with this alternative hypothesis [Fer-
reira and Zwinderman, 2006]. Our implementation uses this step. Obviously,
it is also possible to test for effects in both directions.
Illustration with simulation
The performance of the test can be illustrated by simulation in the following
way. Let us consider one dataset from our simulation study, with by construc-
tion 20% differentially expressed probes. We then filter varying proportions of
probes out of the dataset, using the various filter statistics. In each case, we
evaluate the achieved FDR.
We next permute column labels independently per probe, generating a
dataset with no differential expression. Now varying ratios of probes are again
filtered out from the data, and the empirical distribution of the (null) p-values
is compared to the uniform by a Kolmogorov-Smirnov test. This is repeated
for 1000 permutations, yielding a distribution of the Kolmogorov-Smirnov p-
values.
As can be seen from figure C.4, our test tends to not reject the null hypothe-
sis that the p-values follow a uniform distribution, when signal or variance filters
are used. Coherently, in these cases the achieved FDR remains approximately
constant even after filtering. On the other hand, with the fold change filter the
FDR-bias test indicates clearly that a potential bias can be introduced, which is
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Figure C.4: Results of our proposed FDR bias test, for the various filter statis-
tics and FDR methods considered, and a range of filtered-out ratios (x-axis).
For each filtered-out ratio, the empirical distribution of the null p-values is
represented by a boxplot, and the p-value resulting from its comparison to the
uniform is given above the graph: the p-value if not significant, ’***’ if less
than 0.001. In all cases, the FDR was controlled at 0.05. Also shown are the
lines representing the achieved FDR values, obtained from the non-permuted
data using: BH (red), aBH (dark blue), qvalue (light blue) and BY (green). In
addition, the Bonferroni correction is shown in black for comparison. A solid,
thin black line, representing the FDR threshold is also shown. Results of the
q-value method could only be obtained for the variance and signal filter, as for
the fold change and test-statistic ones the p-value range was reduced, violating
an assumption of the method.
confirmed by the achieved FDR increasing with the filtered-out fraction, whilst
the FDR control level was kept fixed.
C.10 Experimental data: childhood leukemia
Here we show two additional figures obtained with this dataset. First in figure
C.5 we display the estimated power achieved in the analysis, as a function of the
fraction of features filtered out of the data. We use the same filter statistics as
before, namely the fold change, the overall variance and the signal. We consider
three subsets of randomly selected samples from each subtype, of sizes 8, 16 and
24 respectively. In all cases, the empirical Bayes model used to compare the
two groups is first fitted to each subset of samples involving all features, then
the filter is applied leaving out increasing fractions of the features. The power
is estimated by comparing the proportion of differentially expressed features
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Figure C.5: Achieved power (true positive rate) as function of the fraction
filtered out for the different filter statistics, fixing the FDR with each method at
0.05. Computations are done using randomly selected subsets of n = 8, 16, 24
samples from each subtype considered. Differential expression is evaluated
using limma, and p-values are FDR-corrected.
left in the data, out of all in the whole dataset (all samples and all features)
declared differentially expressed.
Also the false positive rate behaviour can be examined, which corresponds
to the proportion of the features declared differentially expressed in the subset
under study but not in the whole dataset (all samples), divided by the total
of features not declared significant in the whole dataset. As before, the fold
change filter has the biggest effect, with the signal and variance filter remaining
stable. As this represents the fraction of all null features that are wrongly seen
as differentially expressed, it increases with the sample size due to the increasing
number of features declared differentially expressed as the sample size increases.
This fraction stabilizes and decreases again after a certain sample size threshold
(data not shown).
C.11 Performance of filtering using the Wilcoxon test
Our results hold for more general analysis models, in particular when another
test is used other than the Student-t test. To show this, let us assume that
instead the Wilcoxon rank-sums test was used. By re-running the simulation
study achieved power and FDR can be evaluated as a function of the fraction
of features filtered out, as before. For simplicity, we consider only BH as FDR
correction. We can see from figure C.6 that the obtained curves are very similar
to those obtained using the Student’s t-test (figures 5.5 and C.2).
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Figure C.6: FDR (left) and actual power (right) as function of the fraction fil-
tered out for the different filter statistics, fixing the FDR (Benjamini-Hochberg
method) with each method at 0.05. Values shown are the mean FDR over 1000
simulated datasets (the variability of the FDR is small - not shown). Filters
are: solid line = fold change, dashed = signal, dotted = variance. In all cases
the proportion of differentially expressed genes is fixed at 0.20.
C.12 FDR methods without uniform assumption for
null p-values distribution
Here we have concluded that FDR methods that rely on the assumption that
null p-values follow a uniform distribution can be biased if filtering is used
prior to the statistical analysis. However, this could be circumvented by us-
ing another method to estimate the FDR that does not rely on this assump-
tion. Indeed, a number of such FDR methods has been proposed. One is
Efron’s local FDR, which assumes only that the test statistic distribution has
a symmetric, unimodal distribution, and estimates the actual density empiri-
cally. Other methods that have been proposed include the empirical-Bayes and
bootstrap-based FDR method of Dudoit and co-authors (hereafter bootFDR
[Dudoit et al., 2008]), and the permutation-based methods of Jain and co-
authors [Jain et al., 2005] and of Reiner and co-authors (hereafter permFDR
[Reiner et al., 2003]), the latter based upon previously suggested approaches
which accomodated dependency [Yekutieli and Benjamini, 1999] and used re-
sampling [Benjamini and Yekutieli, 2001]. While permFDR involves estimation
and averaging of the p-values distribution over a number of permutations of
the array labels, bootFDR involves both estimating the proportion of differ-
entially expressed genes π0 using empirical Bayes, as well as estimation of the
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Figure C.7: Relationship between achieved FDR (top row) and achieved power
(bottom row) with filtering (y-axis) and without it (x-axis), for the fold change
(left) and variance (right) filters. The light gray line represents x = y. Colours
indicate the FDR estimation method used: BH-FDR (light blue), permFDR
(pink) and bootFDR (dark green).
null p-values distribution using bootstrap.
Efron’s local FDR cannot in its current form be applied in conjunction with
filters that yield a bimodal or asymetric null test statistic density, such as the
fold-change filter. In addition, the control level of local FDR does not corre-
spond to a unique control level of classic FDR, with Efron himself suggesting
that either 10 or 20% control of the local FDR could correspond to control of
the BH-FDR at 5%. For these reasons, the comparisons that follow exclude
this method. In addition, the method proposed by Jain and co-authors [Jain
et al., 2005] is very similar to permFDR. So we will compare the classic FDR of
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Benjamini and Hochberg[Benjamini and Hochberg, 1995] (BH-FDR) with the
permFDR of Reiner and co-authors [Reiner et al., 2003] and with the bootFDR
of Dudoit and co-authors [Dudoit et al., 2008].
As expected, for the variance filter the observed FDR with and without
filtering are very similar, in contrast with results for the fold-change filter, which
yields a biased FDR compared to when no filtering is used (top row of figure
C.7). With the fold-change filter, permFDR behaves very similarly to BH-
FDR, yielding comparable amounts of FDR bias and of power improvement.
On the other hand, bootFDR yields both FDR bias and power improvement
compared to the other methods. This difference may be due to estimation of π0,
done using empirical Bayes by bootFDR but assumed to be 1 by BH-FDR and
permFDR. Another possible explanation is that all methods make assumptions
in order to estimate the null p-values distribution, which are in their turn
violated by the filtering. Furthermore, the null p-values distribution estimate
is only correct for large samples and if either the sample sizes of both groups
are equal, or the two groups have the same covariance structure, conditions
which often do not hold in practice [Pollard and van der Laan, 2004]. In
practical applications, permutation-based null distribution estimates can also
be biased if, for example, relevant covariates were not included in the model
or in presence of correlation between sample and features [Efron, 2008]. Our
conclusions are that even FDR estimation methods that use an empirical null
p-values distribution may yield FDR bias, and that null p-values distribution
estimation needs to be further studied in the context of filtering.
C.13 Use of filter after multiple testing correction
In this paper we have focussed on examining the effect of filtering prior to sta-
tistical analysis, and showed that some types of filter may introduce bias on
commonly-used methods to estimate the FDR. In practice, researchers some-
times use filtering after multiple testing correction, typically to reduce a list of
differentially expressed genes to only those more likely to be successfully vali-
dated in lab. In theory, there is no guarantee that the reduced list so produced
will involve the same proportion of false positives as the full list generally. How-
ever, for some combinations of test statistic and post-FDR filter statistic the
FDR may be little affected by the post-FDR filter, and it is unclear how the
power is affected.
We use the same simulation study setup as before (section C.8), with 20%
differentially expressed genes and mean differential expression levels generated
at random from a bitriangular distribution. Also, as before the Student-t test is
used to find differentially expressed genes, and genes are dclared as differentially
expressed if their FDR is up to 5%, using Benjamini-Hochberg’s FDR step-up
procedure [Benjamini and Hochberg, 1995]. We then consider three situations:
(A) no filtering is used, (B) a fraction (25 or 50%) of the data is filtered prior to
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Figure C.8: Comparison between observed FDR with no filtering (x-axis, situ-
ation A) with values observed with filtering (y-axis). In all cases the FDR was
controlled at 5%. Blue and black dots: situation C with 10 and 20% left out,
respectively; red and green triangles: situation B with 25 and 50% left out,
respectively. The gray line represents x = y.
multiple testing correction, and (C) a fraction (10 or 20%) of the data is filtered
out from the list of selected features, i.e., after multiple testing correction. In
each situation, the observed FDR (the true proportion of false positives on
the final list of selected genes) and the observed power (the true proportion of
differentially expressed genes included in the final list) are computed.
The observed FDR (figure C.8) is similar regardless of whether and when
filtering is done for the variance and signal filters, whilst the fold change filter
shows an FDR bias with pre-FDR filter but not with post-FDR filter. The
observed power (figure C.9) reflects these observations in general, with the
fold-change filter the only one to yield improved power with pre-FDR filtering.
However, post-FDR filtering yields a slight loss of power in all cases. This
leads us to conclude that post-FDR filtering does not bias the FDR and yields
a small loss of power, in the setting used.
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high-density arrays
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D.1 Supplemental Methods CpG island methylation
study
All neuro-ectodermal cell lines were cultured in DMEM (Invitrogen, Breda,
The Netherlands) containing 10% heat inactivated fetal calf serum (Integro,
Zaandam, The Netherlands), 0.05% fungizone (Invitrogen), 0.1 U/ml penicillin
(Invitrogen), 0.1 µg/ml streptomycine (Invitrogen), 1% 100× glutamax (Invit-
rogen) and 1% 100× non-essential amino acids (MEM, Invitrogen). DNA of
untreated (daily change of medium) and treated cells was isolated using TRIzol
reagent (Invitrogen, Breda, The Netherlands) and checked for quality by gel
electroporesis.
To evaluate genome-wide methylation patterns the Differential Methylation
Hybridization (DMH) technique by Yan et al. [2002] was used. The protocol
was adjusted for smaller DNA input (500 ng) according to Pearlly Yan and
Tim Huang [Stumpel et al., 2009]. In short, DNA samples were fragmented
using MseI (New England Biolabs, Leusden, The Netherlands), linker-ligated
and digested using two methylation-sensitive restriction enzymes BstUI and
HpaII (New England Biolabs). The methylation sensitive digestion enriched
the DNA for methylated fragments, followed by a PCR-based amplification
(figure D.5). All samples with and without treatment were labeled with Cy5
and a commercially available DNA pool (Promega, Leiden, The Netherlands)
was labeled with Cy3. The samples were subsequently hybridized to 244K CpG
island microarrays (Agilent, Amstelveen, The Netherlands). The arrays were
scanned with a 2565AA DNA microarray scanner (Agilent) and the data was
extracted and analyzed by Feature extraction 9.5.3 software (Agilent). Raw
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Cy5 and Cy3 foreground signals were used for further analysis. Data was
deposited at GEO with accession number GSE25225.
D.2 Validation experiments
LUminometric Methylation Assay (LUMA)
Global methylation levels were measured by LUMA [Karimi et al., 2006a,b]. In
short, LUMA is based on differential digestion of the methylation sensitive re-
striction enzyme HpaII and the methylation insensitive restriction enzyme MspI
and thus measures percentage of methylation at CCGG sites. Concomitant di-
gestion with EcoR1 was performed to adjust for DNA input. Quantification
was achieved by a polymerase extension assay using the Pyrosequencer which
estimates the percentage of unmethylated DNA by the HpaII/MspI ratio (more
specifically percentage unmethylated DNA= (HpaII/EcoR1)/(MspI/EcoRI)×100)
[Karimi et al., 2006a,b]. DNA for LUMA analysis was isolated with the QI-
Aamp DNA mini kit (Qiagen). TRIzol isolated DNA resulted in unreliable
peak patterns and background on the pyrosequencer. The SK-N-FI cell line
misses from this analysis.
Methylation-specific polymerase chain reaction (MSP)
For two frequently hypermethylated genes TNFRSF25 (also called DR3) and
TNFRSF10D (also called DcR2) the demethylating treatment effect was vali-
dated in the 6 cell lines. DcR2 primers and reaction conditions were described
by van Noesel et al. [2002]. The primer sequences for DR3 are: TGTGGGGTTGAAG-
GTGGAATTATGAT (unmethylated sense), CACCACACAACCCCACAACCA
(unmethylated antisense) under the same reaction conditions as DcR2 [van
Noesel et al., 2002].
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Figure D.1: DMH: Differential methylation hybridisation (DMH) based pro-
tocol for genome-wide methylation measurements with CpG island arrays.
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Figure D.2: Volcano plot for the selection of the MAQC data: The
volcano plot shows the difference between loess normalization on a subset (1%
of the probes), with a loess normalization using another subset (1% of the
probes). A volcano plot shows − log10(P-value) on the y-axis and the fold-
change on the x-axis. The 0.5% of the largest changes (euclidean distance) are
indicated by arrows, with increasing significance from subset to the full data
indicated by green arrows and decreasing significance in red. The top 100 of
most significant probes are indicated by a + sign.
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Figure D.3: MA-plots for a single cell line (treated and untreated):
The upper panel shows raw data with P-spline and weighted P-spline curves
respectively in green and red. The middle panels shows P-spline normalized
data and the lower panels the weighted P-spline normalization data.
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Figure D.4: MA-plots for all cell lines with weighted P-spline curves
using different methods: The blue curve is obtained without any weights,
the yellow curve with weights of ≈ 250 and the red one with only the subset.
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Figure D.5: Methylation specific PCR for DR3 and DcR2: This figure
shows the appearance or increase of the unmethylated product of DR3 and
DcR2 after treatment with Decitabine and Trichostatin A in most of the cell
lines (U= untreated, T= treated).
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E.1 The integrated analysis method
We propose an integrated analysis of miRNA and mRNA expression based on
the global test [Goeman et al., 2004]. The global test is a generalization for
testing the global null hypothesis of a linear (or generalized linear) regression
model H0 : β1 = β2 = · · · = βp = 0 when the number of features exceeds the
number of samples (p >> n).
In our integrated analysis the linear model with only an intercept is tested
against the alternative model y = Xβ. Here yn×1 represents the expression
profile of a certain miRNA and Xn×p the expression profiles of the predicted
mRNA targets for that miRNA. The number of targets p is generally larger
than the number of samples n.
A useful interpretation of the global test for the linear model is as a sum
of squared covariances between predictors and responses (see section 5 of Goe-
man et al. [2004]). Consider the sample covariance, ry,x between a miRNA
expression profile yn×1 and a single target xn×1 given by:
ry,x =
1
n− 1
n∑
k=1
(yk − y¯n)(xk − x¯n) = (x− x¯n)
T (y− y¯n)
n− 1 , (E.1)
where y¯n and x¯n denote the sample means of miRNA and mRNA expression
profiles, y¯n and x¯n are vectorized versions (note that ry,x = rx,y). For multiple
mRNA profiles Xn×p the p × 1 vector of the sample covariances, ry,X can be
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expressed as:
ry,X =
1
n− 1
n∑
k=1
(yk − y¯n)(Xkj − X¯j) = (X− X¯)
T (y− y¯)
n− 1 . (E.2)
Note that this expression is valid even when the number of targets exceeds
the number of samples p > n, and again rTy,X = rX,y. Goeman et al. [2004]
proposed the following test statistics proportional to the squared sample co-
variance
(y− y¯n)TXXT (y− y¯n)
(y− y¯n)T (y− y¯n) ∝ r
T
y,Xry,X. (E.3)
The global test can be used not only for a continuous response, as explained
here, but also for binary, multi-class, count and survival, and adjustment for
confounders is possible [Goeman et al., 2005, 2011]. Moreover, they derived an
asymptotic distribution for the test statistics, which is exact in case the linear
model with normal errors is correct [Goeman et al., 2011]. See Figure E.3 for a
comparison of z-scores from the global test with pairwise correlations between
three miRNAs and their predicted targets.
E.2 Prioritization of microRNAs and their targets:
quantitative comparison of global test, correlation
and lasso
Motivation
Several methods have been proposed to jointly analyse microRNA (miRNA)
and mRNA expression data, taking also into account in silico predicted tar-
gets. Some of them are based on the strength and direction of the Pearson
correlation coefficient between the expression profiles the miRNAs and targets
[Ben-Moshe et al., 2012]. Others have used lasso [Tibshirani, 1996], a penalized
regression algorithm, for example using miRNA expression profiles as responses
and targets expression profiles as covariates [Engelmann and Spang, 2012, Lu
et al., 2011]. However, a quantitative comparison between these methods in
this context is still lacking. Here we perform a quantitative comparison between
our proposed method, based upon global test, with using correlation or lasso.
We do this by considering for each miRNA all mRNAs that are predicted as
possible targets, as given by the overlap of three target prediction tools; Tar-
getScan, MicroCosm and PITA. Firstly, we show how results using these three
approaches are obtained and can be related in general, when a large number
of samples is available. Secondly, we assess sensitivity and specificity of each
method using a subsampling approach where the full data set is taken as the
truth. The prostate cancer data described in the Methods section of the Main
text is used in these comparisons.
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Theoretical background
Correlations are statistics that are used to measure association between pairs of
variables. The Pearson correlation is in particular often used to measure linear
correlation. There exists a statistical test, due to Pitman [1939], to assess how
likely a Pearson correlation coefficient is to be observed if the variables are in
fact uncorrelated. If that is the case, a function of the computed correlation
is distributed as a Student’s t-statistic with n − 2 degrees of freedom, where
n represents the sample size. In the context of our problem, one correlation
coefficient and its p-value is produced per miRNA:mRNA pair.
The lasso [Tibshirani, 1996] is a method for fitting regression models so as
to select the most relevant covariates to explain the outcome via shrinkage.
The resulting fit yields thus an interpretable and parsimonious function of the
covariates. Because its aim is interpretability, it may eliminate covariates that
are associated with outcome, after retaining a single one that represents that as-
sociation. In addition, the amount of shrinkage must be estimated empirically,
so that different fits are not necessarily comparable. Furthermore, each lasso
fit yields at most n non-zero coefficients, or n non-zero variables are selected,
where n represents the sample size. This is both sensible and desirable for rep-
resentation and interpretability purposes, but not if the objective is to find all
(or as many as possible) active mRNA targets, especially in small studies when
just tens of samples are available - some miRNAs may have hundreds of possi-
ble mRNA targets [Bartel and Chen, 2004]. Finally, no statistical significance
can be assigned to the resulting fit, so prioritization of miRNAs according to
how likely they are of regulating mRNAs in the context under study is not
straightforward.
The global test [Goeman et al., 2004] was proposed as a test to assess
association between an outcome and a set of variables. It can be seen as a test
for the variance of a random effect relating the variable set and the outcome.
As such, it can be put in the same context as ridge regression, another well-
known penalized regression algorithm. However, as it focuses on testing the
association, rather than on describing the association as ridge regression, it
eliminates the need for estimating the amount of shrinkage. In addition, as
the name says, it is a test and thus produces p-values which enable objective
prioritization of miRNAs. Furthermore, for each miRNA the test statistic can
be decomposed into the independent contributions of each mRNA towards the
final statistic, allowing for prioritization of the mRNAs too. The global test
statistic corresponds to the average of these independent, per miRNA:mRNA
pair, test statistics.
Under the null hypothesis that there is no association between miRNA and
the many mRNAs’ expression, the global test statistic has asymptotically a
distribution that is a weighted sum of independent chi-square distributions,
each with 1 degree of freedom. If the test is used with a linear model, rather
than a generalized linear model, this holds exactly. In particular, for a single
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miRNA:mRNA pair the test statistic has a chi-square distribution, under a
linear model and the null hypothesis, and the test statistic itself is a function
of the data via the Pearson correlation. Since the statistical test statistic for a
Pearson correlation can be approximated by the normal distribution for large
sample sizes, its square is also asymptotically distributed as a chi-square. With
appropriate standardizations, thus, these two methods lead asymptotically to
the same p-value for each miRNA:mRNA pair. So, in the context of linear
models, the global test could be seen as an extension of Pearson correlation
testing to the case where multiple miRNA:mRNA pairs are considered.
General comparison
Here we give an overview of results obtained with the three methods, using the
prostate cancer data set involving 139 prostate cancer samples for which both
miRNA and mRNA expression profiles are available (a total of 267 miRNAs
and 20035 mRNAs were used). For the global test, we computed for each
miRNA the global test statistic and its p-value, as well as the test statistics for
each miRNA:mRNA pair involved. The Pearson correlations for the relevant
miRNA:mRNA pairs were also computed. Finally, for each miRNA lasso was
fitted using the predicted mRNA targets.
Figure 7.4 summarizes these results. The miRNAs are ordered according
to the global test statistic, with increasing significance from left to right, and
the vertical line separates not significant (left) from significant (right) asso-
ciations, all according to the global test. The stacked points represent the
global test statistics separately for each target, coloured according to signifi-
cance (black if significant, i.e. p-value < 0.001 after multiple testing correction
using Benjamini-Hochberg’s FDR; grey otherwise). The size of each point re-
flects the absolute correlation coefficient. Two things are immediately evident
from the figure. Firstly, the ordering given by the correlation (square size)
is indeed the same as the ordering given by the pairwise global test statistics
(square height), as expected due to the relationship between the Pearson cor-
relation coefficient and the per-pair global test statistic. This is evident by the
fact that, for each vertical column of points, squares increase in size from bot-
tom to top. Secondly, the global test significance helps separating the miRNAs
according to the average association they display with target mRNAs: signifi-
cant test results may be yielded by a handful of particularly large correlations,
or by a larger group of medium-sized correlations. Making such distinctions is
not straightforward using pairwise results alone.
Still in Figure 7.4, red squares indicate miRNA:mRNA pairs selected by
lasso, so that in each vertical column of squares the red ones represent mRNA
targets with a non-zero lasso-regression coefficient. It is clear that lasso does
not always prioritize large correlation, with some mRNAs with small (and not
significant) correlation being selected by lasso (red squares amongst mostly
grey ones), and some miRNA:mRNA pairs displaying large correlation and
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zero lasso-regression coefficient (large black squares on the top). This can be
explained by the fact that lasso aims at an interpretable and parsimonious
representation, selecting one of any possible set of correlated mRNAs asso-
ciated with the outcome miRNA, and thus neglecting individually relevant
miRNA:mRNA pairs. In addition, lasso does not help to prioritize miRNAs
playing a significant role in mRNA regulation: red squares are observed on
both sides of the vertical line.
Assessing consistency in sensitivity and specificity
Subsampling
In order to compute a method’s sensitivity (true positive rate) and specificity (1
- false positive rate), the truth must be known. In the context of miRNA:mRNA
expression associations, existing databases include but a small number of val-
idated targets to date, with this number further reduced if interest lies in one
specific tissue or condition. In contrast, lists of predicted mRNA targets per
miRNA amount to at least tens, if not hundreds of mRNAs per target predic-
tion tool. Thus restricting results lists to pairs already validated greatly limits
conclusions. A simulation study is normally used in such situations, but given
that this complex biological problem is not yet well understood by biologists,
involving many-to-many relations and various other issues, it is hardly possible
to come up with a simulation setup anywhere near realistic. Furthermore, the
three methods considered here are well-understood in the literature of statisti-
cal methods (see ‘Theoretical background’ of the previous section), so there is
not a great deal to be learned from such a simulation study. What still lacks
is an understanding of these methods’ consistency for studies of various sizes.
To enable assessment of how consistent sensitivity and specificity measure-
ments are in a realistic setting, we used here a subsampling approach on the
prostate cancer dataset. This involved drawing different-sized subsets of the
data proportional to 40%, 80% and 90% of the total number of samples. For
each method, results obtained on each subset were compared to the results for
the full dataset, assumed to represent thus the truth. In this way it is possi-
ble to calculate ‘true’ positive and ‘false’ positive rates per method. For each
subset size, 25 subsets were used in order to obtain a sense of the variability of
the estimates. Note, however, that the rates here computed are relative to the
method, so care must be taken when comparing rates between methods.
Pearson correlation and the global test
For each miRNA, our approach yields a p-value derived from the global test.
This indicates evidence or not for the miRNA’s role in regulating expression
levels of mRNAs predicted as its targets. The list of p-values computed using all
samples is first produced. Then, for each subset, p-values are again computed
for the same miRNAs and their lists of mRNA targets. Using different signif-
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icance thresholds, we compute how many miRNAs are found to be significant
or not, in the subset and in the full dataset. The Benjamini-Hochberg multiple
testing correction procedure was applied to each generate list of p-values. So
true and false positive rates here refer to proportions of miRNAs found in the
full dataset that were also found in a subset, and proportions not found in the
full dataset that were however declared significant in a subset, respectively.
Pearson correlation p-values were also produced for all relevant miRNA:mRNA
pairs. We then needed to choose a rule to summarize results per miRNA: we
declared that a miRNA played a role in mRNA expression regulation if its
largest correlation yielded a p-value below a threshold.
Results are grouped per threshold used (significance level) and per subsam-
ple size (see Figure E.4 A and B). In each case, a boxplot is made of true positive
rates (coloured boxes) and false positive rates (white boxes with only contours
coloured). It is clear from the figure that both sensitivity and specificity in-
crease as either the subset size (given by the box colour) or the significance level
increase, as expected. Also, the global test and Pearson correlation selections
of miRNAs yield relatively the same sensitivity with respect to the full dataset
if either 80% or more of the samples are chosen. When only 40% of the samples
are used, the global test displays a larger drop in sensitivity than correlation.
This is a consequence of taking as a summary the smallest p-value of all cor-
relations per miRNA, which also yields more false positives: while the global
tests yields a proportion of false positives in agreement with the significance
level taken, selected miRNAs by Pearson correlation include many more false
positives than expected. This illustrates well the advantage of taking a set of
mRNAs together to perform the association test: only consistent associations
results are found, and false positives are kept under the correct control level.
Pairwise association measures, such as the Pearson correlation, are more likely
to be influenced by individual pairs with large associations, which may well
arise by chance.
Here a summary of results per miRNA had to be chosen for the Pearson
correlation coefficients. Other alternative summaries could be used. However,
any other arbitrary choice would likely have disadvantages due to first evaluat-
ing results per miRNA:mRNA pair, then summarizing per miRNA. Indeed, the
global test has been shown to display more power against pairwise association
testing, for alternative hypotheses often of practical interest [Goeman et al.,
2006]. Thus, we are confident that the conclusions above can be qualitatively
extended to other methods involving summaries in two stages.
Lasso and the global test
Lasso regression results cannot be summarized per miRNA in a meaningful,
practical way. All lasso fits yield at least one non-zero coefficient, so each
miRNA always has at least one mRNA left in the regression fit. The number
of non-zero coefficients remaining in the fit may also not be of relevance. So,
186
E.2. PRIORITIZATION OF MICRORNAS AND THEIR TARGETS
for this comparison, we decided to focus on pairs of miRNA:mRNA selected,
where for each miRNA only mRNAs that are predicted targets are considered,
as before.
For each miRNA, the true positive rate represents the proportion of
miRNA:mRNA pairs with a global test p-value below a threshold using the
subset, compared with those found when using the full dataset. Similarly, the
false positive rate is the proportion of pairs found in the subset, that were not
found using the full dataset. As argued in section “Theoretical background”,
results for the Pearson correlation are identical to those of the global test (Fig-
ure E.4 C). For the lasso, no threshold can be used, so each subset yields a list
of mRNAs with non-zero coefficients, which is compared with the full dataset
list to yield true and false positive rates (Figure E.4 D).
The trend of increasing true positive rate is still seen for increasing subset
sizes for both the global test and lasso. Also, false positive rates remain under
control for global test results, in spite of splitting the results per pair. Lasso
keeps its false discoveries very much under control, compared to pairs found
using the full dataset. So, we can conclude that both methods yield consistent
results.
It is, however, surprising that true positive rates do not go above 80%
when results per pair are considered, in contrast with when results per set are
evaluated. Indeed, if we compare the graphs for the global test only (Figures
E.4 A and C), we can see that once it is used considering gene sets, true positive
rates are reassuringly consistent with those of the full data set, but they drop
considerably when using miRNA:mRNA pairs, for any choice of threshold and
significance level . This illustrates another advantage of using our approach
with gene sets: it yields results that are more consistent with the full data set.
Conclusion
The results of the quantitative comparison strengthen the choice of the global
test for our approach for integrated analysis of miRNA and mRNA expression
data. The global test has similar sensitivity compared to Pearson correlation
but as important better specificity at an useful range of significance levels. For
the prioritization of miRNAs lasso does not perform well, furthermore, the
selected targets are not consistent in highly correlated targets.
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Figure E.1: Venn diagrams showing the overlap between the significantly pre-
dicted miRNA:mRNA pairs with validated pairs from TarBase, miRTarbase
and miRecords and with manually collected pairs specifically for prostate can-
cer by Lu et al.. In A the significantly predicted miRNA:mRNA pairs are
obtained by predicting miRNA expression using the predicted targets from
the strict overlap between TargetScan, PITA, microCosm. In B the reversed
model (mRNAmiRNA) is used again with strict overlap of predicted targets.
In C the same model as in A is used except now using partial overlap between
TargetScan, PITA, microCosm and D is similar to C with the partial overlap.
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Figure E.2: Venn diagrams showing the overlap between the significantly pre-
dicted miRNA:mRNA pairs using original (miRNAmRNA) and the reverse
(mRNAmiRNA) models with validated pairs from TarBase, miRTarbase and
miRecords and with manually collected pairs specifically for prostate cancer by
Lu et al.. In A and B the significantly predicted miRNA:mRNA pairs are ob-
tained using the predicted targets from the strict overlap between TargetScan,
PITA, microCosm, where in B only negatively associated miRNA:mRNA pairs
are shown. In C and D partial overlap between TargetScan, PITA, micro-
Cosm was used, where in D only negatively associated miRNA:mRNA pairs
are shown. Actually, A combines Supplementary Figure 2a and 2b and C
Figures 2c and 2d. B and D are similar to A and C except only negatively
associated pairs are shown.
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Figure E.3: Comparison between the global test z-scores, representing the in-
dividual contributions for each target to the test statistic, and the pairwise
miRNA:mRNA correlations. For each miRNA the overlapping targets between
three prediction tools were used. Global test z-scores are proportional to the
square of the pairwise correlation between miRNA and mRNAs. In red are
the validated targets. A mmu-miR-133a with validated targets Foxc1, Ptbp2
and Arfip2, B mmu-miR-26a with validated targets: Epha2, Ezh2, Thrap3
and Fbxl19 and C mmu-miR-22 with validated targets: Wasf1, Arpc5, Nr3c1,
Arfip2 and Fbxl19.
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Figure E.4: Assessment of consistency in sensitivity and specificity using global
test, correlation and lasso for the integrated analysis of miRNA and mRNA ex-
pression data. A subsampling approach was used using the prostate cancer
dataset. For each method, results obtained on subsets were compared to the
results on the full dataset, assumed to represent the truth. The boxplots sum-
marize true positive rates (solid) and false positive rates (transparent) of 25
subsets sampled from the full dataset for three subsets sizes 40%, 80% and
90% proportional to the original size of the data indicated in red, green and
blue. True positive rates and false positive rates were calculated at three differ-
ent significance levels 0.01, 0.05 and 0.1 using the Benjamini-Hochberg multiple
testing correction (x-axis). Assessment of consistency in sensitivity and speci-
ficity for the selection of miRNAs A global test and B Pearson correlation (not
possible for lasso). C and D present the assessment of consistency in sensitiv-
ity and specificity for the selection of targets respectively, for global test and
Pearson correlation (results are identical) and lasso. See Supplementary Sec-
tion “Prioritization of miRNAs and their targets: quantitative comparison of
global test, correlation and lasso” for details.
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E.2. PRIORITIZATION OF MICRORNAS AND THEIR TARGETS
Table E.2: Overview of miRNA mmu-miR-22 targets with strict overlap be-
tween the three prediction tools TargetScan, microCosm and PITA, including
the individual P-value for association with mmu-miR-22 expression. The tar-
gets in bold are those that were used in validation experiments.
Negative associations Positive associations
Entrez Symbol P-value Entrez Symbol P-value
83767 Wasf1 0.00415 12391 Cav3 0.03830
233902 Fbxl19 0.07967 67092 Gatm 0.05633
76932 Arfip2 0.12357 232087 Mat2a 0.06313
19159 Cyth3 0.13766 56323 Dnajb5 0.12344
67771 Arpc5 0.18739 30948 Bin1 0.14616
14815 Nr3c1 0.31383 104263 Kdm3a 0.21728
17536 Meis2 0.32297 66240 Kcne1l 0.36748
22329 Vcam1 0.34188 107271 Yars 0.36959
21345 Tagln 0.45586 216850 Kdm6b 0.52230
16852 Lgals1 0.47281 27281 Hrasls 0.54816
67074 Mon2 0.51303 70315 Hdac8 0.54844
230596 Prpf38a 0.54665 380916 Lrch1 0.55348
108112 Eif4ebp3 0.55761 234964 Ccdc67 0.57421
67877 Naa20 0.57213 229700 Rbm15 0.58935
231887 Pdap1 0.66938 13831 Epc1 0.60787
219094 Khnyn 0.76520 17257 Mecp2 0.69782
75770 Brsk2 0.90336 276952 Rasl10b 0.75741
12226 Btg1 0.97314 16918 Mycl1 0.78415
18285 Odf1 0.78714
245469 Pdzd4 0.82422
239318 Plcxd3 0.87587
56349 Net1 0.96627
12978 Csf1r 0.97297
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Table E.3: Overview of miRNA mmu-miR-133a targets with strict overlap be-
tween the three prediction tools TargetScan, microCosm and PITA, including
the individual P-value for association with mmu-miR-133a expression. The tar-
gets in bold are those that were used in validation experiments. The underlined
targets could not be cloned.
Negative associations Positive associations
Entrez Symbol P-value Entrez Symbol P-value
108013 Celf4 0.00224 19272 Ptprk 0.00593
17300 Foxc1 0.00895 19228 Pth1r 0.12300
13017 Ctbp2 0.00962 216190 Appl2 0.35621
29813 Zfp385a 0.01417 78593 Nrip3 0.47936
56195 Ptbp2 0.02202 243312 Elfn1 0.48227
76932 Arfip2 0.02642 216549 Aftph 0.52637
56526 Sept6 0.03019 14167 Fgf12 0.54326
23873 Faim 0.03089 21854 Timm17a 0.57684
19671 Rce1 0.04030 108071 Grm5 0.82700
13345 Twist2 0.04046 19277 Ptpro 0.87367
19052 Ppp2ca 0.05338 13803 Enc1 0.93127
13639 Efna4 0.05490 226896 Tcfap2d 0.99817
70122 Mllt3 0.07573 99326 Garnl3 0.99828
21873 Tjp2 0.08822
223870 Senp1 0.09540
13681 Eif4a1 0.14082
17925 Myo9b 0.14631
66940 Shisa5 0.14670
17886 Myh9 0.14858
105522 Ankrd28 0.18061
14573 Gdnf 0.18734
19053 Ppp2cb 0.19079
74442 Sgms2 0.21377
83675 Bicc1 0.22581
72587 Pan3 0.26695
12757 Clta 0.28853
66500 Slc30a7 0.39067
22218 Sumo1 0.40243
66588 Cmpk1 0.40671
217214 Nags 0.55364
69257 Elf2 0.63642
76787 Ppfia3 0.66704
242667 Dlgap3 0.80598
224530 Acat3 0.80903
16873 Lhx5 0.86312
56389 Stx5a 0.86889
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Table E.4: Overview of miRNA mmu-miR-26a targets with strict overlap be-
tween the three prediction tools TargetScan, microCosm and PITA, including
the individual P-value for association with mmu-miR-26a expression. The tar-
gets in bold are those that were used in validation experiments. The underlined
targets could not be cloned.
Negative associations Positive associations
Entrez Symbol P-value Entrez Symbol P-value
230753 Thrap3 0.00975 232288 Frmd4b 0.01550
15402 Hoxa5 0.01171 215814 Ccdc28a 0.02566
14163 Fgd1 0.01818 27402 Pdhx 0.04878
18753 Prkcd 0.03200 22057 Tob1 0.04902
59027 Nampt 0.03455 60613 Kcnq4 0.05639
15234 Hgf 0.03738 11535 Adm 0.05794
233902 Fbxl19 0.04957 22652 Mkrn3 0.06351
18578 Pde4b 0.05925 320538 Ubn2 0.07083
68732 Lrrc16a 0.06011 18712 Pim1 0.07706
23873 Faim 0.07397 234875 Ttc13 0.09932
264064 Cdk8 0.08502 77044 Arid2 0.10003
66197 Cks2 0.09182 22065 Trpc3 0.11484
15446 Hpgd 0.13005 30928 Zfp238 0.12068
72549 Reep4 0.18209 231290 Slc10a4 0.14205
13836 Epha2 0.18782 213753 Zfp598 0.16269
66980 Zdhhc6 0.20504 229488 Fam160a1 0.17340
52708 Zfp410 0.22480 320213 Senp5 0.17368
14056 Ezh2 0.23016 231051 Mll3 0.17701
16647 Kpna2 0.23713 74132 Rnf6 0.18469
242466 Zfp462 0.31819 16650 Kpna6 0.19984
233833 Tnrc6a 0.41264 231600 Chfr 0.22044
12018 Bak1 0.44428 19212 Pter 0.23132
235441 Usp3 0.59153 208177 Phldb2 0.24115
217154 Stac2 0.60107 99167 Ssx2ip 0.25254
13445 Cdk2ap1 0.61613 76608 Hectd3 0.31757
66695 Aspn 0.69023 71795 Pitpnc1 0.32328
503610 Zdhhc18 0.73335 19893 Rpgr 0.39004
77128 A930001N09Rik 0.78505 227446 2310035C23Rik 0.41007
17532 Mras 0.89128 228983 Osbpl2 0.49724
100019 Mdn1 0.90387 74159 Acbd5 0.49863
192285 Phf21a 0.51123
22241 Ulk1 0.51187
17125 Smad1 0.51643
225055 Fbxo11 0.52365
238130 Dock4 0.53668
106369 Ypel1 0.53955
58242 Nudt11 0.54688
71069 Stox2 0.56330
14479 Usp15 0.56787
67071 Rps6ka6 0.64564
407823 Baz2b 0.67234
19266 Ptprd 0.68593
71673 Rnf215 0.71344
13831 Epc1 0.76169
269275 Acvr1c 0.76807
15112 Hao1 0.95523
APPENDIX E. INTEGRATED ANALYSIS
Table E.5: Number of predicted miRNA:mRNA pairs, unique miRNAs and
unique mRNAs for the prostate cancer data using the additional features of
our approach a) strict versus partial overlap, b) reversing the model. For both
approach we also summarized the results when only looking at the negative
associations.
Strict Overlap Partial Overlap
Original model Reversed model Original model Reversed model
all negative all negative all negative all negative
pairs 1732 809 1653 775 13098 6229 12978 6187
miRNA 175 154 203 172 223 212 286 269
mRNA 1128 588 961 523 4845 3086 3876 2642
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E.2. PRIORITIZATION OF MICRORNAS AND THEIR TARGETS
Table E.6: Overview of miRNA target pairs with strict overlap between the
three databases TargetScan, Microcosm and PITA using the original model
strict overlap original model.txt
Table E.7: Overview of miRNA target pairs with strict overlap between the
three databases TargetScan, Microcosm and PITA using the reversed model
strict overlap reversed model.txt
Table E.8: Overview of miRNA target pairs with partial overlap between the
three databases TargetScan, Microcosm and PITA using the original model
partial overlap original model.txt
Table E.9: Overview of miRNA target pairs with partial overlap between the
three databases TargetScan, Microcosm and PITA using the reversed model
partial overlap reversed model.txt
These tables are available from http://www.humgen.nl/bioinf/iterson et
al 2013 suppl tables6-9.zip
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FSSPA: General Sample Size and Power
Analysis for high-dimensional genomic data
Maarten van Iterson and Rene´e de Menezes
F.1 Introduction
Power and sample size analysis or sample size determination is concerned with
the question of determining the minimum number of samples necessary to
demonstrate the existence (or absence) of a difference between two or more
populations of interest. The number of samples should be sufficient in that
the statistical test will reject the null hypothesis, when there really exists a
difference, with high probability or power.
Sample size determination for experiments involving high-dimensional data
has several challenges as a multiple testing problem is involved, furthermore
the occurrence of differentially and nondifferentialy expressed genes and that
each gene individually has an effect size and a standard deviation leading to
a distribution of effect sizes and standard deviations complicates the problem
even further.
Power and sample size analysis for high-dimensional data was initiated by
Lee and Whitmore [2002]. The multiple testing problem was controlled using
the easy to apply family-wise error rate. Since controlling the family-wise
error rate is too conservative for microarray data, methods were proposed that
control the multiple testing problem using the false discovery rate [Pawitan
et al., 2005, Liu and Hwang, 2007, Tong and Zhao, 2008]. Recently, those
methods were adapted for using pilot-data in order to obtain more realistic
estimates of the power [Ferreira and Zwinderman, 2006, Ruppert et al., 2007,
Jørstad et al., 2008].
This vignette describes SSPA, a package implementing a general pilot data-
based method for power and sample size determination for high-dimensional
genomic data, such as those obtained from microarray or next-generation se-
quencing experiments. The method is based on the work of Ferreira and Zwin-
201
APPENDIX F. VIGNETTE SSPA PACKAGE
derman [2006] and generalized as described by van Iterson et al. [2009, 2013].
By means of two simple commands (pilotData(), sampleSize()), a re-
searcher can read in their data –a vector of test statistics– and compute the
desired estimates. Other functions are provided that facilitate interpretation of
results. Simulation data is used to show the general functionality and flexibility
of the package and two interesting biological case study are shown.
F.2 Simulated data
This simulation study represents a two group microarray experiment with m =
5000 features andN = 10 samples per group. Let Rij and Sij , i = 1, . . . ,m, j =
1, . . . , N be random variables where Sij ∼ N(−µi/2, 1) andRij ∼ N(µi/2, 1) with
the first µi = 0 for i = 1, . . . ,m0 and the remaining µi for i = m0+1, . . . ,m were
drawn from a symmetric bi-triangular distribution as described by Langaas
et al. [2005]. A total of 25 data sets were simulated with the proportion of
non-differentially expressed features fixed at π0 = 0.8. Additional technical
noise is added to the model using X ∼ log(eR + eǫ) and Y ∼ log(eS + eǫ) with
ǫ ∼ N(0, 0.12), so that the noise is positive and additive.
> library(SSPA)
> library(genefilter)
> set.seed(12345)
> m <- 5000
> J <- 10
> pi0 <- 0.8
> m0 <- as.integer(m*pi0)
> mu <- rbitri(m - m0, a = log2(1.2), b = log2(4), m = log2(2))
> data <- simdat(mu, m=m, pi0=pi0, J=J, noise=0.01)
> statistics <- rowttests(data, factor(rep(c(0, 1), each=J)))$statistic
Deconvolution
The first step in doing the sample size and power analysis is creating a object
of class PilotData which will contain all the necessary information needed for
the following power and sample size analysis; a vector of test-statistics and the
sample sizes used to compute them. A user-friendly interface for creating an
object of PilotData is available as pilotData().
Several ways of viewing the content of the PilotData object are possible ei-
ther graphically or using a show-method by just typing the name of the created
object of PilotData:
> pdD <- pilotData(statistics = statistics,
+ samplesize = sqrt(1/(1/J +1/J)),
+ distribution="norm")
> pdD
Formal class 'PilotData' [package "SSPA"] with 5 slots
..@ statistics : num [1:5000] -1.98854 -0.00589 -1.26628 0.74421 -0.76088 ...
..@ samplesize : num 2.24
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Figure F.1: Diagnostic plots of test statistics and p-values of the pilot-data:
Upper-left histogram of test statistics, Upper-right histogram of p-values,
Lower-left qq-plot of test statistics and Lower-right p-values in increasing order.
..@ pvalues : num [1:5000] 0.0468 0.9953 0.2054 0.4567 0.4467 ...
..@ distribution: chr "norm"
..@ args : list()
> plot(pdD)
Now we can create an object of class SampleSize which will perform the es-
timation of the proportion of non-differentially expressed genes and the density
of effect sizes. Several options are available see ?sampleSize.
The density of effect size can be shown by a call to plot(). When there
are both up- and down-regulated genes a bimodal density is observed.
> ssD <- sampleSize(pdD, control=list(from=-6, to=6))
> ssD
Formal class 'SampleSize' [package "SSPA"] with 10 slots
..@ pi0 : num 0.781
..@ lambda : num [1:512] 0 0 0 0 0 0 0 0 0 0 ...
..@ theta : num [1:512] -6 -5.98 -5.95 -5.93 -5.91 ...
..@ control :List of 11
.. ..$ method : chr "deconv"
.. ..$ pi0Method : chr "Langaas"
.. ..$ pi0 : num [1:90] 0.1 0.11 0.12 0.13 0.14 0.15 0.16 0.17 0.18 0.19 ...
.. ..$ adjust : logi TRUE
.. ..$ a : num 0.5
.. ..$ bandwith : NULL
.. ..$ kernel : chr "fan"
.. ..$ from : num -6
.. ..$ to : num 6
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density of effect sizes
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Figure F.2: Estimated density and true (bitriangular) density of effect sizes
using deconvolution.
.. ..$ resolution: num 512
.. ..$ verbose : logi FALSE
..@ info :List of 1
.. ..$ pi0: num 0.767
..@ statistics : num [1:5000] -1.98854 -0.00589 -1.26628 0.74421 -0.76088 ...
..@ samplesize : num 2.24
..@ pvalues : num [1:5000] 0.0468 0.9953 0.2054 0.4567 0.4467 ...
..@ distribution: chr "norm"
..@ args : list()
> plot(ssD, panel = function(x, y, ...) {
+ panel.xyplot(x, y)
+ panel.curve(dbitri(x), lwd=2, lty=2, n=500)
+ }, ylim=c(0, 0.6))
Estimating the average power for other sample sizes then that of the pilot-
data can be performed with the predictpower()-function. The user can also
give the desired false discovery rate level.
> Jpred <- seq(10, 20, by=2)
> N <- sqrt(Jpred/2)
> pwrD <- predictpower(ssD, samplesizes=N, alpha=0.05)
> matplot(Jpred, pwrD, type="b", pch=16, ylim=c(0, 1),
+ ylab="predicted power", xlab="sample size (per group)")
> grid()
The density of effect sizes can also be estimated using a conjugate gradient
algorithm method=’congrad’ or using Tikhonov regularization method=’tikhonov’
see figures .7 and .8 for the results on the simulated data in the Appendix.
204
F.3. CASE STUDY: NUTRIGENOMICS MICROARRAY DATA
10 12 14 16 18 20
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
sample size (per group)
pr
ed
ict
ed
 p
ow
e
r
Figure F.3: Predicted power for sample sizes larger than the pilot-data.
F.3 Case Study: Nutrigenomics microarray data
In this first example a set consisted of Affymetrix array data derived from
a nutrigenomics experiment in which weak, intermediate and strong PPARα
agonists were administered to wild-type and PPARα-null mice is used. The
power and sample size analysis confirms the hierarchy of PPARα-activating
compounds previously reported and the general idea that larger effect sizes
positively contribute to the average power of the experiment.
PPARα is a transcription factor that is activated upon binding by a vari-
ety of agonists, both of synthetic and natural origin. In this experiment the
outcome of specific PPARα activation on murine small intestinal gene expres-
sion was examined using Affymetrix GeneChip Mouse 430 2.0 arrays. PPARα
was activated by several PPARα-agonists that differed in activating potency.
Data of three agonists were used, namely Wy14,643, fenofibrate and trilinolenin
(C18:3). The first two compounds belong to the fibrate class of drugs that are
widely prescribed to treat dyslipidemia, whereas trilinolenin is an agonist fre-
quently found in the human diet. For intestinal PPARα, Wy14,643 is the most
potent agonist followed by C18:3 and fenofibrate. Since time of exposure also
affects the effect size, intestines were collected 6 hrs (all three agonists) or 5
days (Wy14,643 and fenofibrate only) after exposure. Expression estimates of
probesets were obtained by GC-robust multi-array (GCRMA) analysis, em-
ploying the empirical Bayes approach for background adjustment, followed by
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quantile normalization and summarization. For each compound and exposure
time, lists of moderated t-test statistics were computed, using the empirical
Bayes linear regression model as implemented in limma, for each contrast rep-
resenting the effect of compound in PPARα-null mice compared to wild-type
mice. For more details see van Iterson et al. [2009].
> library(lattice)
> data(Nutrigenomics)
> str(Nutrigenomics)
'data.frame': 16540 obs. of 5 variables:
$ wy5d : num 2 1.22 1.19 -1.14 1 0.86 4 -1.83 -2.64 3.04 ...
$ feno5d: num 2 -1.03 -1.11 0.33 0.22 0.22 0.24 0.36 1.73 0.54 ...
$ X1836h: num 2.5 -2.3 -0.56 0.06 -0.89 -0.09 2 -2.12 -1.47 -1.69 ...
$ wy6h : num 2 1.12 0.21 -0.68 -1.06 -0.4 1.82 -1.71 1.2 1.03 ...
$ feno6h: num 2.22 0.76 -0.37 -0.07 -1.9 ...
> pd <- apply(Nutrigenomics, 2,
+ function(x) pilotData(statistics=x[-1],
+ samplesize=sqrt(x[1]),
+ distribution="norm"))
> ss <- lapply(pd, sampleSize,
+ control=list(pi0Method="Storey", a=0, resolution=2^10, verbose=FALSE))
> ##ss <- lapply(pd, sampleSize,
> ## method = "congrad",
> ## control=list(verbose=FALSE, resolution=2^10, from=-10, to=10))
>
> compounds <- c("Wy14,643", "fenofibrate",
+ "trilinolenin (C18:3)", "Wy14,643",
+ "fenofibrate")
> exposure <- c("5 Days", "6 Hours")
> effectsize <- data.frame(
+ exposure = factor(rep(rep(exposure, c(2, 3)), each=1024)),
+ compound = factor(rep(compounds, each=1024)),
+ lambda = as.vector(sapply(ss,
+ function(x)x@lambda)),
+ theta = as.vector(sapply(ss,
+ function(x)x@theta)))
> print(xyplot(lambda~theta|exposure, group=compound, data=effectsize,
+ type=c("g", "l"), layout=c(1,2), lwd=2, xlab="effect size", ylab="",
+ auto.key=list(columns=3, lines=TRUE, points=FALSE, cex=0.7)))
> samplesize <- seq(2, 8)
> averagepower <- data.frame(
+ power = as.vector(sapply(ss,
+ function(x) as.numeric(predictpower(x, samplesize=sqrt(samplesize))))),
+ exposure = factor(rep(rep(exposure, c(2, 3)), each=length(samplesize))),
+ compound = factor(rep(compounds, each=length(samplesize))),
+ samplesize = rep(2*samplesize, 5))
> print(xyplot(power~samplesize|exposure, group=compound, data=averagepower,
+ type=c("g", "b"), layout=c(1,2), lwd=2, pch=16, xlab="sample size (per group)",
+ ylab="", auto.key=list(columns=3, lines=TRUE, points=FALSE, cex=0.7)))
F.4 Case Study: deepSAGE of wild-type vs Dclk1
transgenic mice
In this example we will show how our method can be applied to count data
of an RNA-seq experiment. We will use the data described by ’t Hoen et al.
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TRANSGENIC MICE
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Figure F.4: Estimated densities of effect sizes for the nutrigenomics experiment.
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Figure F.5: Predicted power curves for the nutrigenomics experiment.
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[2008] comparing gene expression profiles in the hippocampi of transgenic δC-
doublecortin-like kinase mice with that of wild-type mice. Data is available
from GEO (GSE10782).
and analyzed using the generalized linear model approach implemented in
edgeR. A tag-wise dispersion parameter was estimated using the Cox-Reid ad-
justed profile likelihood approach for generalized linear models as implemented
in edgeR. Using a treatment contrast, we tested per tag if there was a genotype
effect using the likelihood ratio statistic. This test statistic follow asymptoti-
cally a χ2 distribution with one degree of freedom.
> ##files contains the full path and file names of each sample
> targets <- data.frame(
+ files=files,
+ group=rep(c("DCLK", "WT"), 4),
+ description=rep(c("transgenic (Dclk1) mouse hippocampus",
+ "wild-type mouse hippocampus"), 4))
> d <- readDGE(targets) ##reading the data
> ##filter out low read counts
> cpm.d <- cpm(d)
> d <- d[rowSums(cpm.d > 1) >= 4, ]
> design <- model.matrix(~group, data=d$samples)
> ##estimate dispersion
> disp <- estimateGLMCommonDisp(d, design)
> disp <- estimateGLMTagwiseDisp(disp, design)
> ##fit model
> glmfit.hoen <- glmFit(d, design,
+ dispersion = disp$tagwise.dispersion)
> ##perform likelihood ratio test
> lrt.hoen <- glmLRT(glmfit.hoen)
> ##extract results
> tbl <- topTags(lrt.hoen, n=nrow(d))[[1]]
> statistics <- tbl$LR
> library(lattice)
> data(deepSAGE)
> str(deepSAGE)
num [1:44882] 133.5 93.8 89.5 88.8 87.4 ...
> pd <- pilotData(statistics=deepSAGE,
+ samplesize=8, distribution="chisq", df=1)
> ss <- sampleSize(pd, method="congrad",
+ control=list(trim=c(0, 0.98), symmetric=FALSE, from=0, to=10))
> pwr <- predictpower(ss, samplesize=c(8, 16, 32))
> op <- par(mfcol=c(2,1), mar=c(5,4,1,1))
> plot(ss@theta, ss@lambda,
+ xlab="effect size", ylab="", type="l")
> plot(c(8, 16, 32), pwr,
+ xlab="sample size", ylab="power", type="b", ylim=c(0,1))
> grid(col=1)
> par(op)
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Figure F.6: Estimated density of effect sizes and predicted power curve for the
deepSAGE experiment.
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F.5 Session info
The version number of R and packages loaded for generating the vignette were:
• R Under development (unstable) (2013-02-01 r61814),
x86_64-unknown-linux-gnu
• Locale: LC_CTYPE=en_US.UTF-8, LC_NUMERIC=C,
LC_TIME=en_US.UTF-8, LC_COLLATE=en_US.UTF-8,
LC_MONETARY=en_US.UTF-8, LC_MESSAGES=en_US.UTF-8, LC_PAPER=C,
LC_NAME=C, LC_ADDRESS=C, LC_TELEPHONE=C,
LC_MEASUREMENT=en_US.UTF-8, LC_IDENTIFICATION=C
• Base packages: base, datasets, graphics, grDevices, methods, stats,
tools, utils
• Other packages: genefilter 1.41.2, lattice 0.20-13, limma 3.15.14,
qvalue 1.33.0, SSPA 1.99.5
• Loaded via a namespace (and not attached): annotate 1.37.3,
AnnotationDbi 1.21.12, Biobase 2.19.3, BiocGenerics 0.5.6,
compiler 3.0.0, DBI 0.2-5, grid 3.0.0, IRanges 1.17.35, parallel 3.0.0,
RSQLite 0.11.2, splines 3.0.0, stats4 3.0.0, survival 2.37-2, tcltk 3.0.0,
XML 3.95-0.1, xtable 1.7-1
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.1 Conjugate Gradient
> pdC <- pilotData(statistics = statistics,
+ samplesize = sqrt(2*J),
+ distribution="t",
+ df=2*J-2)
> ssC <- sampleSize(pdC,
+ method="congrad",
+ control=list(from=-6, to=6, resolution=250))
> plot(ssC, panel = function(x, y, ...)
+ {
+ panel.xyplot(x, y)
+ panel.curve(2*dbitri(2*x), lwd=2, lty=2, n=500)
+ },
+ xlim=c(-2,2), ylim=c(0, 1.2))
.2 Tikhonov regularization
> ssT <- sampleSize(pdC,
+ method="tikhonov",
+ control=list(resolution=250,
+ scale="pdfstat",
+ lambda = 10^seq(-10, 10, length=50),
+ verbose=FALSE,
+ modelselection="lcurve"))
> plot(ssT, panel = function(x, y, ...)
+ {
+ panel.xyplot(x, y, type="b")
+ panel.curve(2*dbitri(2*x), lwd=2, lty=2, n=500)
+ },
+ xlim=c(-2,2), ylim=c(0, 1.2))
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Figure .7: Estimated density and true (bitriangular) density of effect sizes using
a conjugate gradient algorithm.
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Figure .8: Estimated density and true (bitriangular) density of effect sizes using
Tikhonov regularization.
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ATurboNorm: A fast scatterplot smoother
with applications for microarray
normalization
Chantal van Leeuwen and Maarten van Iterson
A.1 Introduction
This vignette show how piecewise constant P-splines [Eilers and Marx, 1996]
can be used for normalization of either single- or two-colour data. The pspline()-
function can be used for two-colour data objects of type RGList and MarrayRaw
from respectively from limma Smyth [2005] and from the package marray . For
single colour microarray data wrapper functions are writting based on the affy
[Bolstad et al., 2003] functions normalize.loess() and
normalize.AffyBatch.loess() namely normalize.pspline() and
normalize.AffyBatch.pspline(). Also a panel-function, panel.pspline(),
is available for adding the smoothed curve to lattice [Sarkar, 2009] graphic pan-
els.
The P-spline smoother introduced by Eilers and Marx [1996] is a com-
bination of B-splines with a difference penalty on the regression coefficients.
P-splines belong to the family of penalized splines using B-spline basis func-
tions, where the penalization is on the curvature of the smoothed function.
For the P-splines of Eilers and Marx [1996], a discrete approximation to the
integrated squared second derivative of the B-splines is made. This results in
an easy-to-construct penalty matrix, and the resulting band-diagonal system
of equations can be efficiently solved. Using piecewise constant B-splines as a
basis makes the construction of the B-spline basis even easier. The resulting
linear system of equations can be solved either using a QR decomposition or a
Cholesky decomposition [Hastie et al., 2001].
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Additionally to the P-spline smoother proposed by Eilers and Marx [1996]
we introduce a weighted P-spline smoother. The weighted P-spline smoother
leads to the following system of equations:
(X ′WX + λD′D)βˆ = X ′Wy, (A.1)
where X is the B-spline basis matrix (with X ′ its transpose), W is a diagonal
matrix of weights, D is a matrix operator for the second-order differences and
y represents the vector of observations. The value of penalty parameter, λ, can
be determined by cross-validation, for example. The original P-spline smoother
of Eilers and Marx [1996] hasW , the identity matrix. When piecewise constant
basis functions are used, both X ′WX and X ′Wy become diagonal matrices,
and can be constructed very efficiently [Eilers, 2004]. The regression coefficients
of the weighted P-spline smoother are now given by:
βˆ = (X ′WX + λD′D)−1X ′Wy. (A.2)
See for a detailed description of the method and several applications van Iterson
et al. [2012].
A.2 Smoothing using piecewise constant P-splines
The main workhorse of the package is the function turbotrend(). Given data
the function returns an object containing the smoothed values and some addi-
tional information like, effective degrees of freedom, optimized penalty value,
λ, and the generalized cross-validation error at the optimal penalty value.
The following toy example shows the use of the turbotrend(). First we
load the library and generate some data:
> library(TurboNorm)
> funky <- function(x) sin(2*pi*x^3)^3
> m <- 100
> x <- seq(0, 1, length=m)
> y <- funky(x) + rnorm(m, 0, 0.1)
Next we plot the data and the underlying function that generated the data
together with the smoothed curves based on the original piecewise constant
B-spline basis.
> plot(x, y, type='p', xlab="", ylab="")
> curve(funky, add=TRUE)
> fitOrig <- turbotrend(x, y, n=15, method="original")
> lines(fitOrig, col="green", type='b', pch=1)
In order to get some more detail on the regression parameters a show-
method is implemented.
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> fitOrig
Call:
turbotrend(x = x, y = y, n = 15, method = "original")
Effective degrees of freedom: 6.014623
Number of bins: 15
Penalty value: 10.30344
Number of robustifying iterations: 0
GCV : 0.05649688
A.3 Normalization of single- and two-colour data
For single colour microarray data normalization the following functions are
available normalize.pspline() and normalize.AffyBatch.pspline() these
functions are based on functions for normalization from the affy package.
The pspline()-function can be used for normalization of two-colour mi-
croarray data. The data input is either an object of type RGList as defined
in the package limma or an object of type MarrayRaw defined in the package
marray . The pspline()-function recognizes the type of the object and returns
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the normalized object of the same type, i.e. MAList and MarrayNorm.
Here is an example code using the swirl-data from marray . Using the
option showArrays=2 the smoothed curve is plotted together with the data in
a MA plot for array 2 (by default no plot is shown).
> library(marray)
> data(swirl)
> x <- pspline(swirl, showArrays=2, pch=20, col="grey")
A.4 Normalization of array-based DNA methylation
data
Here we show how a weighted normalization can be performed. This is es-
pecially useful for array-based DNA methylation data, where there is large
number of differential methylation expected.
Using data(methylation) a random subset of the data of one of the cell
lines described in the paper by van Iterson et al. [2012] is loaded as an RGList.
The element weights of the RGList contains the subset of invariant fragments,
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those without methylation-sensitive restriction sites, as a logical matrix where
each colunm represents an array those fragments that are part of the subset
are TRUE and those that are not FALSE. The data dependent weight is in this
example approximately 250.
> library(TurboNorm)
> data(methylation)
> indices <- methylation$weights[,1]
> weights <- rep(1, length(indices))
> weights[indices] <- length(indices)/sum(indices)
> MA <- normalizeWithinArrays(methylation,
+ method="none", bc.method="none")
> labels <- paste("NMB", c("(untreated)", "(treated)"))
> labels <- paste(rep(c("Raw"), each=2), labels)
>
First we transform the intensities to M- and A-values without background
correction and then the normalization is performed both weighted P-spline and
ordinary lowess using limma. Now we use the lattice in order to illustrate the
difference. We highlight the invariant subset in black.
> data <- data.frame(
+ M=as.vector(MA$M),
+ A=as.vector(MA$A),
+ Array=factor(rep(labels, each=nrow(MA$A)),
+ levels=rev(labels)))
> library(lattice)
> print(xyplot(M~A|Array, xlab="", ylab="", data=data, type='g',
+ panel = function(x, y) {
+ panel.xyplot(x, y, col="grey")
+ lpoints(x[indices], y[indices], pch=20, col="black")
+ panel.pspline(x, y, weights = weights, col="red", lwd=2)
+ panel.loess(x, y, col="green", lwd=2)
+ }))
This example also shows how the panel.pspline()-function can be used.
The smoothed curve obtained by the P-spline smoother can be added to lattice
graphics.
A.5 Details
This document was written using:
• R Under development (unstable) (2013-02-01 r61814),
x86_64-unknown-linux-gnu
• Locale: LC_CTYPE=en_US.UTF-8, LC_NUMERIC=C,
LC_TIME=en_US.UTF-8, LC_COLLATE=en_US.UTF-8,
LC_MONETARY=en_US.UTF-8, LC_MESSAGES=en_US.UTF-8, LC_PAPER=C,
LC_NAME=C, LC_ADDRESS=C, LC_TELEPHONE=C,
LC_MEASUREMENT=en_US.UTF-8, LC_IDENTIFICATION=C
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• Base packages: base, datasets, graphics, grDevices, methods, parallel,
stats, tools, utils
• Other packages: Biobase 2.19.3, BiocGenerics 0.5.6, convert 1.35.0,
lattice 0.20-13, limma 3.15.14, marray 1.37.0, TurboNorm 1.7.2
• Loaded via a namespace (and not attached): affy 1.37.4, affyio 1.27.1,
BiocInstaller 1.9.6, compiler 3.0.0, grid 3.0.0, preprocessCore 1.21.1,
zlibbioc 1.5.0
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